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doi: 10.1016/j.exphObjective. This study aimed to investigate the mechanisms of action of WEB-2170, an inverse
agonist of platelet-activating factor receptor, capable of inducing apoptosis in human acute
myelogenous leukemia (AML) cells.
Material and Methods. Gene expression profiling followed by cytofluorimetric, morphologic,
and biologic analyses were used to monitor WEB-2170 effects in AML cell lines (ie, NB4,
KG1, NB4-MR4, THP1, and U937) and blasts from patients with different AML (M0LM5)
subtypes. PTEN silencing with small interfering RNA was also performed.
Results. We have demonstrated that drug-mediated cytostasis/apoptosis in NB4 cells is char-
acterized by upregulation of cyclin G2, p21/WAF1, NIX, TNFLa, and PTEN expression, and
downregulation of cyclin D2 and BCL2 expression. We observed an increase in PTEN protein
accompanied by a decrease in phospho-extracellular signal-regulated kinase 2 (ERK2) and
phospho-AKT, and by forkhead box O3a (FOXO3a) cytoplasmic-nuclear translocation; the
mitochondrial cytochrome C release and PARP cleavage marked the late apoptotic steps.
We have found that WEB-2170 triggered apoptosis in NB4, KG1, and NB4-MR4 cells where
PTEN was expressed, but not in THP1 and U937 cells where PTEN was absent. Finally, we
show that PTEN silencing in NB4 cells by PTEN-specific small interfering RNA resulted in
a significant reduction of drug-induced apoptosis.
Conclusion. We demonstrated that WEB-2170 is a powerful antileukemic agent with inter-
esting translational opportunities to treat AML and described mechanisms of drug-induced
intrinsic and extrinsic apoptosis both in AML cell lines and blasts from AML patients by
addressing PTEN as the master regulator of the whole process.  2009 ISEH - Society for
Hematology and Stem Cells. Published by Elsevier Inc.Acute promyelocytic leukemia (APL) with t(15;17)
chromosomal translocation is a subtype of acute myelogene-
ous leukemia (AML) that can be successfully cured by all-
trans-retinoic acid (ATRA) targeted therapy toward theurenzana contributed equally to this work.
: Francesco Paoletti, Ph.D., Department of Experi-
Oncology, Viale G. B. Morgagni 50, 50134 Firenze,
co.paoletti@unifi.it
associated with this article can be found, in the
i:10.1016/j.exphem.2009.07.002
front matter. Copyright  2009 ISEH - Society for Hemat
em.2009.07.002PML/RARa fusion protein [1]. ATRA can also be used in
combination with other agents to treat elderly AML patients
carrying the nucleophosmin-1 mutation [2]. This approach,
however, is not effective on ATRA-resistant APL forms
and other AML (non-APL) subtypes [3], which are refrac-
tory to ATRA-induced differentiation [4]. Therefore, the
current treatment for the bulk of the other AML subtypes still
consists of high-dose chemotherapy with potential life-
threatening toxicity and acquired drug resistance [5].
Inhibitors of histonedeacetylases [6] andDNAdemethylating
agents [7,8]haveproducedadvancements inepigenetic controlof
chromatin assembling and influenced greatly gene expressionology and Stem Cells. Published by Elsevier Inc.
Figure 1. WEB-2170 induces modulation of genes involved in cell cycle progression and apoptosis in NB4 cells. (A) Eisen tree map computed using the
GeneSpring gene tree and the Pearson correlation equation on the modulated probe sets belonging to the categories: (i) cell cycle-related genes; (ii) pro- and
antiapoptotic genes. The signal-based coloring legend is shown at the bottom of the panel. Microarray analysis was performed in duplicate for both untreated
and 0.5 mM WEB-2170treated NB4 cells. UT_15 untreated cells, replicate 1; UT_25 untreated cells, replicate 2; WEB_15WEB-2170treated cells,
replicate 1; WEB_25WEB-2170treated cells, replicate 2.
1177C. Cellai et al./ Experimental Hematology 2009;37:1176–1185[9], thus providing additional tools for cancer therapy [10].
Indeed, epigeneticmodulators are functional to set up anenviron-
ment permissive for cell differentiation and/or apoptosis, butmay
not always be sufficient themselves to trigger these processes
without the cooperation of other proactive signals. It is of great
interest, therefore, to identify and characterize new agents
capable of inducing cytostasis, differentiation, and apoptosis in
AML cells, and supporting the action of epigenetic modulators
and conventional chemotherapy so as to decrease effective ther-
apeutic doses and untoward consequences to the host.
We previously showed that WEB-2170 da ligand of
platelet-activating factor receptor (PAF-r) originally synthe-
sized from an anxiolytic triazolobenzodiazepine [11,12]d
could also promote murine erythroleukemia cell maturation
[13] and trigger apoptosis in ATRA-sensitive and -resistant
APL cell lines, and in blasts from patients with APL [14].
The present study aimed to understand mechanisms of
WEB-2170-induced cytostasis and apoptosis in the APL
cell line NB4, as well as to assess drug efficacy in other
AML cell lines and, eventually, ex vivo in blasts from
patients with different (M0 through M5) AML subtypes.
The results reported herein show that WEB-2170 effects
were mainly related to the enhanced expression of PTEN
(phosphatase and tensin homologue, MMAC/TEP1) [15],
the product of a tumor suppressor gene that is lost ormutated in a number of human solid neoplasms [16,17],
while still frequently conserved in myeloid leukemia
[18,19]. PTEN is known to counter the activity of the
phosphatidylinositol 3-kinase (PI3K)/serine or threonine-
specific protein kinase, PI3K/AKT, and extracellular
signal-regulated kinase 2 (ERK2) signaling pathways that
are implicated in the control of cell-cycle progression and
apoptosis, and in leukemogenesis [20]. PTEN-mediated
inhibition of PI3K/AKT and ERK pathways allows the
translocation of the transcription factor forkhead box O3a
(FOXO3a) to the nucleus [21], thus promoting the selective
expression of molecules involved in cell growth arrest and
activation of apoptosis. Eventually, two facts supported the
key role of PTEN in governing WEB-2170mediated
effects: first, apoptosis occurred only in PTEN-positive
AML cells and second, PTEN silencing in NB4 cells
resulted in a significant reduction of drug efficacy.Materials and methods
Cell lines, leukemic blasts, culture conditions,
and assay for inverse agonist activity of WEB-2170
Different AML cell lines, namely KG1 (M1), NB4 (M3), NB4-
MR4 (M3), THP1 (M5), and U937 (M5) have been employed.
Figure 1. (Continued). (B) Cyclin G2, p21/WAF1, cyclin G2 as well as BCL2, NIX, TNFa, and PTEN messenger RNA levels from NB4 cells either
untreated (open bars) or treated (closed bars) for 24 hours were assayed by quantitative reverse transcriptase polymerase chain reaction. Results were the
mean 6 standard deviation of three independent experiments; asterisks indicated significant differences between treated and untreated cells;
***p! 0.001; ** p! 0.01). Inverse agonist activity of WEB-2170. (C; gray box) HEK293 cells, stably transfected with the platelet-activating factor
receptor (PAF-r) were incubated for 45 minutes without (open bar) and with either 10 nM PAF (dashed bar) or 10 mM WEB-2170 (closed bar); then inositol
phosphate (IP) accumulation was measured as previously reported [data from 22]. Data were expressed as fold increase or decrease of IP over basal condi-
tions and represented as the means 6 standard error of three independent experiments performed in triplicate.
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previously [14]. Leukemic blasts from bone marrow aspirate
and/or peripheral blood of 19 newly diagnosed AML patients
with M0 through M5 subtypes were obtained after informed
consent and according to the Ethics Hospital Committee guide-
lines (Helsinki declaration). Blasts and normal peripheral blood
mononuclear cells were isolated by centrifugation on lympho-
cyte separation medium (Eurobio, Les Ulis Cedex, France)
and then cultured as described for leukemia cell lines. Human
embryonic kidney cells HEK293, stably transfected with PAF-
r were also used as the model to assess WEB-2170 inverse
agonist activity as described previously [22].Reagents
WEB-2170 [11] (Boehringer Ingelheim Pharma KG,
Biberach, Germany) was dissolved in dimethyl sulfoxide
(Sigma-Aldrich, St Louis, MO, USA) and stock solutions
(512 mM) were stored at room temperature in the dark.
The dimethyl sulfoxide vehicle did not interfere with
WEB-2170 activities. All other chemicals employed
were reagent grade.RNA extraction, microarray analysis,
and quantitative reverse transcriptase
polymerase chain reaction
(QRT-PCR) experiments
For details on methodologies and the primers used see
Supplementary materials.
Cell lysate preparation, cell
fractionation, sodium dodecyl sulfate
polyacrylamide gel electrophoresis, and Western blotting
Harvested cells were resuspended in a lysis buffer containing
a cocktail of proteinase inhibitors (Calbiochem, Merck
KGaA, Darmstadt, Germany), then sonicated and submitted
to sodium dodecyl sulfate polyacrylamide gel electropho-
resis (SDS-PAGE) separation and Western blot as reported
elsewhere [14]. Proteins from distinct subcellular compart-
ments have been isolated by using the ProteoExtract Subcel-
lular Proteome Extraction Kit (Calbiochem) as suggested by
the manufacturer. Membranes were probed with primary
antibodies against phospho-ERK1/2, ERK1/2, p53, PTEN,
p21/WAF1, and a-tubulin (Santa Cruz Biotechnology, Santa
Cruz, CA, USA); phospho-AKT, AKT, and PARP (Cell
Figure 2. NB4cells are induced to growth arrest and apoptosis byWEB-2170.Cells have been incubated for 24 and 48 hourswith orwithout 0.5 mMWEB-2170
to assess: (A) the % of propidium iodide (PI)stained NB4 cells in different phases of the cell cycle as determined by flow cytometry; (PI labeling, X-axis; total
events, Y-axis). Cells with a DNA content!2 N (sub-G1 fraction) were representative of an apoptotic population; (B) WEB-2170induced time-dependent
release of mitochondrial cytochrome C into the cytosol, and PARP cleavage, by Western blotting; a-tubulin was used to show equal sample loading. WEB-
2170 caused an increase in PTEN protein, decrease in phospho-ERK2 and phospho-AKT, and induced nuclear translocation of FOXO3a, in NB4 cells treated
as above. (C) Total cell extractswere analyzed by immunoblotting for PTEN, phospho-ERK1/2 andERK1/2, phospho-AKT,AKT, p21/WAF1and p53protein;a-
tubulin was used as the reference protein; (D) PTEN and FOXO3a protein partitioning in the cytosolic and nuclear fraction of NB4 cells at different times of
incubation with/without the drug (see Materials and Methods). Histone H4 was also immunodetected at 48 hours to assess the purity of the isolated cellular
compartments. Results were from a typical experiment out of three.
1179C. Cellai et al./ Experimental Hematology 2009;37:1176–1185Signaling Technology, Danvers, MA, USA); and FOXO3a
and histone H4 (Upstate Biotechnology, Lake Placid, NY,
USA and Millipore, Billerica, MA, USA). Horseradish per-
oxidaseconjugated IgG preparations were used as
secondary antibodies; the electrochemiluminescence (ECL)
procedure was employed for development.
Cell cycle analysis and determination of apoptosis
Cell cycle distribution was determined by using the propi-
dium iodide (PI)hypotonic citrate method with a FACScan
flow cytometer (Becton-Dickinson, San Jose, CA, USA)
[23]. Apoptosis was assessed either cytofluorimetrically
by using the Annexin-V Fluos/PI detection kit (Roche
Molecular Biochemicals, Mannheim, Germany), or
morphologically by examining stained cytosmears as re-
ported previously [14]; a microscope (Nikon Eclipse,
mod. 50i) equipped with a digital camera (DS-5 M
USB2) (Nikon Instruments, Florence, Italy) was employed.PTEN silencing with small interfering RNA
Exponentially growing NB4 cells were harvested, and
approximately 2 106 cells were electroporated with
100 mL human Nucleofector solution (Amaxa Biosystems,
Gaithersburg, MD, USA) and 100 nM SMARTpool siRNA
for PTEN (a mix of four small interfering RNA (siRNA)
directed to different parts of human (GenBank accession
no. NM_00314) PTEN mRNA (Dharmacon; cat. #M-
003023-02), or 100 nM siCONTROL nontargeting siRNA
no. 1 (Dharmacon; cat. #D-001206-13-05), by a Nucleo-
fector instrument (Amaxa Biosystems) according to manu-
facturer’s instructions. Transfection efficiency was 90%,
as assessed in parallel with Cy3-labeled siGLO RISC-
free siRNA. Immediately after electroporation, the cells
were suspended in the complete medium and incubated
for the indicated time with or without WEB-2170. Mock
transfection was performed with the Nucleofector solution
alone.
Figure 3. WEB-2170 triggers apoptosis in KG1, NB4, and NB4-MR4 cells but not in THP-1 and U937 cells. (A) Different acute myelogenous leukemia
(AML) cell lines were treated with or without 0.5 mM WEB-2170 for 48 and 72 hours and analyzed by flow cytometry using Annexin V Fluos/PI assay to
detect the percentage of apoptotic cells over control rates. Results were the average 6 standard deviation of three independent experiments. (B) A typical
Annexin-Vfluorescein isothiocyanate (FITC)/PI dot plot of either NB4 or U937 cells treated with/without WEB-2170 for 48 hours. X-axis, the fluorescent
intensity of Annexin-V; Y-axis, the fluorescent intensity of PI. Values reported in each panel indicated the percent of necrotic cells (upper left, UL), late
apoptotic cells (upper right, UR), live cells (lower left, LL), and early apoptotic cells (lower right, LR). Similar results were obtained from other two inde-
pendent experiments. (C) Western blot of PTEN in different AML cell lines either untreated or treated for 48 hours as above; a-tubulin was used as the
reference protein. (D) The cytosolic and nuclear fractions of U937 cells were isolated as reported here and probed for FOXO3a by Western blot. Purity
of the two subcellular fractions was assessed by the presence of histone H4. Results were from a typical experiment out of three.
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All data were statistically analyzed by Student’s t-test.
Significance was determined by analysis of variance fol-
lowed by Newman-Keuls posttests using Prism version
4.0 (GraphPad software, San Diego, CA, USA).Results
Gene expression profiling and QRT-PCR analysis
of either untreated and WEB-2170-treated NB4 cells
In order to define the transcriptome changes induced by
WEB-2170 treatment, we assessed the gene-expression
profile of NB4 cells incubated with/without 0.5 mM
WEB-2170 for 24 hours was assessed using the Affymetrix
HG-U133A GeneChip array. These data have been depos-
ited in the Gene Expression Omnibus MIAME compliant
public database (Supplementary Table E1, online only,
available at www.exphem.org). Using the filtering proce-
dure described in Materials and Methods, we selected
a list of 600 probesets as changing genes in all the four
pair-wise comparisons between untreated andWEB-2170treated NB4 cells (Supplementary Table E2,
online only, available at www.exphem.org). This gene list
was uploaded onto the Database for Annotation, Visualiza-
tion and Integrated Discovery tool 2007 (http://david.
abcc.ncifcrf.gov/) to identify prevalent categories in the
gene-ontologycontrolled vocabulary family ‘‘biological
process.’’ Supplementary Table E3 (Online only, available
at www.exphem.org) shows that the prevalent categories
that increased in WEB-2170treated NB4 cells were nega-
tive regulation of cell proliferation, positive regulation of
cell death, induction of apoptosis, and caspase activation.
Conversely, the prevalent categories downregulated by
WEB-2170 were negative regulation of apoptosis and posi-
tive regulation of cell proliferation. Next, we analyzed
expression of genes involved in the regulation of cell
growth and apoptosis. Gene-expression profiling data
(Fig. 1A) underlined the downregulation of positive regula-
tors of cell-cycle progression, such as CCND2 (cyclin D2),
MYB, and MYC, while growth-arrestrelated genes, such
as the inhibitors of CDK/cyclin complexes CDKN1A
(p21/Waf1) and CDKN2D (p19INK4D), GAS7, and
CCNG2 (cyclin G2) were upregulated by WEB-2170.
1181C. Cellai et al./ Experimental Hematology 2009;37:1176–1185Furthermore, WEB-2170 determined the upregulation
of several proapoptotic genes, such as TNFa, lympho-
toxin B, TRADD, CASP9, CASP8, NIX, and PTEN, while
some antiapoptotic genes including BCL2 were
downregulated.
To validate microarray data, we carried out a quantitative
reverse transcriptase polymerase chain reaction analysis on
a set of differentially expressed selected genes (Fig. 1B)
chosen on the basis of their biological function as master
regulators of both proliferation and apoptosis. After a 24-
hour treatment with WEB-2170, NB4 cells displayed
a marked upregulation of cyclin G2 and p21/WAF1 and
downregulation of cyclin D2 and antiapoptotic BCL2;
concomitantly, expression of proapoptotic NIX, TNFa,
and PTEN was significantly enhanced. These results were
in keeping with those of microarray profiling and, notably,
this trend was already evident at 15 hours of treatment (data
not shown).Inverse agonist activity of PAF-r ligand WEB-2170
The changes in gene expression described here led us to
verify which might be the real pharmacologic effect of
WEB-2170. In fact, the drug did not behave as a pure antag-
onist of PAF-r, as originally believed but, instead, as an
inverse agonist of the receptor as reported for its analogue
WEB-2086 [22]. Inverse agonists are described as having
the opposite effect of pure agonists (such as PAF in this
case) and being capable of sequestering with high affinity
the inactive form of PAF-r and shifting the balance of active
toward inactive PAF-r pool so as to significantly reduce the
PAF-rmediated signal through G proteins. The assay was
carried out by using HEK293 cells stably transfected with
the PAF-r as the model according to procedures reported
previously [22]; our results showed that WEB-2170 acted
as an inverse agonist for PAF-r by decreasing basal levels
of inositol phosphate (IP) production (Fig. 1C) due to
a significant decrease of the PAF-rmediated signal.WEB-2170treated NB4 cells
undergo growth arrest in G0-G1 and apoptosis
Cells were incubated with or without 0.5 mM WEB-2170
and assayed for cell cycle progression. Cytofluorimetric
analyses showed that approximately 66% and 77% of cells
incubated with WEB-2170 for 24 and 48 hours, respec-
tively, were arrested in G0-G1 phase of the cell cycle; this
was in line with the drug-mediated increased expression
of p21/WAF1 and cyclin G2 observed at 24 hours (see
Fig. 1B). Concomitantly, there was a decrease in G2-M
and S cell fraction, and at 48 hours the sub-G1 fraction ac-
counted for nearly half the treated population (Fig. 2A) to
denote the presence of apoptotic cells. This was confirmed
by the time-dependent mitochondrial release of cytochrome
C into the cytoplasm (Fig. 2B, top), and by the cleavage of
PARP after 48 hours of treatment (Fig. 2B, bottom); thesedata were in keeping with our previous observations on
the cleavage of caspase 9, 8, and 3 [14].
WEB-2170 induces PTEN
increase, dephosphorylation of phospho-ERK2 and
phospho-AKT, and nuclear translocation of FOXO3a
Mechanisms of WEB-2170mediated apoptosis in NB4
cells were further been investigated by analyzing some of
the proteins that play a major role in controlling cell growth
and survival. Cells treated for 24 and 48 hours showed
a time-dependent increase in PTEN accompanied by a rapid
decline of phospho-ERK2 and phospho-AKT levels
(Fig. 2C). After 48 hours, WEB-2170 also caused a decrease
in total AKT levels and an increase in p21/WAF1, while no
changes in p53 levels were detected throughout the exper-
iment. To evaluate whether the inhibition of the AKT and
ERK pathway affected the intracellular distribution of
FOXO3a, which is a substrate for both phospho-AKT
[21] and phospho-ERK2 [24], the nuclear and cytoplasmic
fractions of NB4 cells at 9, 24, and 48 hours of treatment
were isolated and analyzed separately. In treated NB4 cells,
there was a progressive translocation of FOXO3a from the
cytosol to the nucleus (Fig. 2D), where it can exert its tran-
scriptional activity, and this event associated with an
increase in cytosolic PTEN and a decrease in both phos-
pho-AKT and phospho-ERK levels. However, after
48 hours of treatment, PTEN translocated in part to the
nucleus, where it may act as a proapoptotic factor [25].
PTEN plays a crucial role in
WEB-2170mediated apoptosis in AML cell lines
In addition to NB4, other human AML cell lines such as
KG1, NB4-MR4, THP-1, and U937 cells were tested at
different times for their response to WEB-2170. Cyto-
fluorimetric analysis with Annexin-V/PI confirmed that
at 72 hours approximately 60% to 70% of treated NB4
cells were apoptotic. KG1 and NB4-MR4 cells were also
sensitive to WEB-2170, yielding about 40% and 55%
apoptotic cells, respectively, while THP1 and U937 cells
seemed to be virtually unaffected by the drug (Fig. 3A).
A comparative cytofluorimetric analysis of NB4 and
U937 cells after a 48-hour incubation period with/without
WEB-2170 clearly showed the marked drug-induced
apoptosis in NB4 cells but not in U937 cells (Fig. 3B).
The differential sensitivity of AML cell lines to drug-
induced apoptosis was explored further by measuring
PTEN after 48 hours of incubation with/without WEB-
2170. PTEN was expressed and upregulated by the drug
in KG1, NB4, and NB4-MR4 cells, while it was absent
in THP1 and U937 cells (Fig. 3C) due to genetic alter-
ations that hampered PTEN translation in U937 [18]
and, probably, also in THP1 cells. The close relationship
between PTEN expression, nuclear translocation of
FOXO3a and apoptosis was confirmed by the fact that
in PTEN-negative U937 cells that were resistant to
Figure 4. PTEN silencing impairs WEB-2170-induced apoptosis in NB4 cells. (A) Aliquots of cells protein lysates (40 ug/20 uL) were subjected to
SDS-PAGE and immunoblotting to detect PTEN or a-tubulin used as loading control. (B) The percentage of apoptotic cells after transfection and 48 hours
of treatment with WEB-2170. Number signs indicated the significant difference (###p! 0.001) in drug-induced cells in PTEN-specific small interfering RNA
(siRNA) transfected cells vs nontargeting siRNA or mock cells.
1182 C. Cellai et al. / Experimental Hematology 2009;37:1176–1185WEB-2170induced apoptosis, FOXO3a was always kept
within the cytoplasm (Fig. 3D).
PTEN silencing in NB4 cells
by specific siRNA decreases drug-induced apoptosis
To further investigate on the key role of PTEN in WEB-
2170mediated apoptosis, we employed PTEN-specific
siRNA to inhibit PTEN expression in either untreated or
drug-treated NB4 cells. PTEN silencing was effective in
downregulating PTEN mRNA levels by approximately five-
fold (Supplementary Fig. E1, online only, available at
www.exphem.org). and decreasing PTEN protein levels
(Fig. 4A); and, notably, decreased significantly WEB-
2170induced apoptosis as compared to control siRNA-
treated cells (Fig. 4B). The mock-transfected cells showed
no significant difference of apoptosis with respect to non-
targeting siRNA-transfected cells.
WEB-2170 triggers apoptosis in blasts
from patients with distinct AML subtypes
Blasts from patients with different AML subtypes (M0
through M5; Fig. 5A) were collected and incubated with
or without 0.5 mM WEB-2170 for 48 hours. Blast sensi-
tivity to drug-induced apoptosis, as quantified by the
Annexin-V/PI assay (Fig. 5B), was considerably high in
all the samples, regardless of the specific AML subtype,
and fell within a range of approximately 35% to 60% of
cell population. The presence of apoptotic cells was
a common morphologic finding in cytosmears of all the
leukemic specimens following treatment (Fig. 5C), butnot of normal peripheral blood mononuclear cells
(PBMC), which were apparently unaffected by the drug.
Notably, WEB-2170treated blasts from patient no.14
with AML (M4 subtype) showed an increase in PTEN
protein and the mitochondrial release of cytochrome C
(Fig. 5D).Discussion
This study demonstrated that WEB-2170 is a powerful anti-
leukemic agent able to increase levels of PTEN protein,
which plays a pivotal role in orchestrating the sequence
of events that eventually commit AML cells to growth
arrest and apoptosis. Microarray data provided strong
molecular support to understand WEB-2170 effects in
NB4 cells and traced the way for further investigation in
other AML cell lines and blasts from AML patients.
Upon addition of WEB-2170 in culture, NB4 cells under-
went growth arrest in G0-G1 and then a massive apoptosis.
These findings were consistent with molecular biology
results showing that WEB-2170 caused the downmodula-
tion of several genes linked to cell proliferation and antia-
poptotic pathways, while other genes promoting cell growth
arrest, as well as the extrinsic and intrinsic apoptosis, were
significantly upregulated. Apparently, the process was inde-
pendent of p53 [26] and histone acetylation [13]. Moreover,
we proved that WEB-2170 acts as an inverse agonist rather
than an antagonist of PAF-r; this way, the drug induces the
functional inactivation of PAF-r accompanied by a decrease
Figure 5. WEB-2170 induces apoptosis in blasts from 19 patients with different acute myelogenous leukemia (AML) subtypes but not in normal peripheral
blood mononuclear cells (PBMC). (A) Clinico-biological characteristics of patients. (B) AML blasts from patients and normal PBMC were incubated in
culture with or without 0.5 mM WEB-2170 for 48 hours, and then analyzed by flow cytometry to assess the percentage of drug-induced apoptotic cells
in treated over untreated cultures. Error bars referred to variations 6 standard deviation of AML cell response to the drug; (C) May-Gru¨nwald/Giemsa
stained cytosmears of cells (magnification: 650) from patient nos. 1 (M0), 2 (M1), 4 (M2), 11 (M3), 14 (M4), and 19 (M5), and from normal PBMC, after
48 hours of treatment with/without 0.5 mM WEB-2170; (D) a typical Western blot of PTEN and of cytochrome C released in the cytosolic fraction of AML
blasts from patient no. 14 (M4 subtype) following a 48-hour treatment with/without the drug; a-tubulin was used as the reference protein.
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1184 C. Cellai et al. / Experimental Hematology 2009;37:1176–1185in IP levels and this might be a critical metabolic event
dictating the downstream inhibition of the PI3K/AKT
signaling pathway.
However, besides these significant drug-induced modi-
fications, we were interested in understanding the mech-
anisms whereby WEB-2170 prompted cytostasis/
apoptosis in AML cells and, possibly, identifying the
key molecules governing these processes. Toward this
end, it was crucial to discover that drug-induced
apoptosis occurred only in AML cells where PTEN
was expressed, but not in AML cells where PTEN was
not translated. Based on these results, a possible mecha-
nism of WEB-2170induced apoptosis in PTEN-express-
ing AML cells might be as follows. The binding of
WEB-2170 to PAF-r prompts the decrease of IP levels
due to its inverse agonist activity, and the increase in
cytoplasmic PTEN protein that exerts its dual phospha-
tase activity. The latter leads to indirect dephosphoryla-
tion of phospho-ERK2 [27], that is also specifically
inactivated by DUSP6 [28], a phosphatase found to be
upregulated by WEB-2170; and hydrolysis of the 30-
phosphate of the residual phosphoinositide PIP3 to PIP2
that contributes to depressing the PIK3/AKT-mediated
signal and, in turn, promotes PTEN allosteric activation
[29]. Under these conditions, both PI3K/AKT and ERK
signaling pathways are negatively regulated and cannot
cooperate to phosphorylate FOXO3a [24] that, once de-
phosphorylated, translocates from cytoplasm to the
nucleus, where activates the transcription of several genes
including those involved in cell growth arrest and
apoptosis. Conversely, PTEN-lacking AML cells are
resistant to WEB-2170induced apoptosis and remain
viable all through the treatment; also, in the absence of
PTEN, FOXO3a is phosphorylated by phospho-AKT
and phospho-ERK and kept in the cytosol, without trans-
locating to the nucleus [30]. Importantly, results of in vi-
tro experiments have been reproduced ex vivo in AML
blasts, which responded well to WEB-2170induced
apoptosis, while normal PBMC were apparently drug-
resistant.
Overall, we demonstrated that WEB-2170 is a potent
inhibitor of IP production and a positive regulator of
PTEN in opposing the PI3K/AKT- and ERK2-mediated
signaling pathways so as to induce growth arrest and
apoptosis in AML cells. WEB-2170mediated upregula-
tion of PTEN function might offer interesting translational
opportunities to treat malignant myeloid disorders where
the gene is still frequently conserved.Acknowledgments
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Supplemental material
RNA extraction and microarray analysis
Total RNA samples from two independent experiments for each
condition (i.e., NB4 cells untreated and treated with 0.5 mM WEB-
2170 for 24 hours) were extracted using RNeasy Mini kit (Qiagen, Va-
lencia, CA, USA). Briefly, biotin-labeled target synthesis was per-
formed, starting from 5 mg total cellular RNA, according to the
protocol supplied by the manufacturer (Affymetrix, Santa Clara, CA,
USA, http://www.affymetrix.com). Labeled cRNA was purified using
Affymetrix GeneChip Sample Cleanup Module and fragmented
(15 mg) as described in the Affymetrix GeneChip protocol. Disposable
RNA chips (Agilent RNA 6000 Nano LabChip kit; Agilent Technolo-
gies, Waldbrunn, Germany, http://www.home.agilent.com) were used to
determine the concentration and purity/integrity of RNA with the Agi-
lent 2100 Bioanalyzer. The biotin-labeled target synthesis reactions, as
well as the Affymetrix HG-U133A GeneChip arrays hybridization,
staining, and scanning, were performed using Affymetrix standard
protocols [1]. The Gene Chip Operating Software absolute analysis
algorithm was used to determine the amount of a transcript messenger
RNA (Signal), while the Gene Chip Operating Software comparison
analysis algorithm was used to compare gene expression levels between
two samples. Present genes were selected as the sequences showing the
Detection call ‘P’ and Signal O100 in both the replicates of at least
one condition. Differentially expressed genes were selected as the
sequences showing a Change call ‘I’ or ‘D’ and Signal Log Ratio
O1 or ! 1 in the pair-wise comparisons between untreated and
WEB-2170treated NB4 cells. The gene list passing this filter was
selected as ‘‘changing genes.’’ The DAVID (Database for Annotation,
Visualization and Integrated Discovery) tool 2007 (http://david.abcc.n-
cifcrf.gov/) was used to examine selected lists of genes to identify
over-representation of functional classes accordingly with gene ontology
(GO) classification. All the data have been deposited in the Gene
Expression Omnibus MIAME compliant public database, at http://
www.ncbi.nlm.nih.gov/geo (Supplementary Table E1).
Quantitative real-time polymerase chain reaction analysis
Complementary DNAwas prepared from 1 mg total RNA, using Super-
script II reverse transcriptase (Invitrogen). The relative quantity of D2, G2,
NIX, BCL2, TNF-a and p21/WAF1 mRNA was measured using the
Applied Biosystems 7500 Fast Real-Time PCR System, and determined
by the comparative CT method using 18S rRNA as normalization gene.
Amplification was performed with the default PCR setting: 40 cycles of
95 C for 15 sec and of 60 C for 60 sec using a SYBR Green based detec-
tion (SYBR Green Master mix; Applied Biosystems) and the following
primers: for cyclin D2, forward 50-CTGCCCCCACCTAGATCATA-30
and reverse 50-TCCCTTATGCTGTA-CTTCAAATAGG-30; for cyclin G2,
forward 50-AAAAAACATCACCTGTAATCTC-ACC-30 and reverse 50-
AGAGATTATCTTGGATGTTCCAGC-50; for NIX, forward 50-CGCC
CCTGCACAACAAC-30 and reverse 50-TCATTGCCATTGCTGCTG-30;
for BCL2, forward 50-GGACAACATCGCCCTGTG-30 and reverse 50-AG
TCTTCAGAGA-CAGCCAGGA-30; for p21/WAF1 forward 50-CTGCC
CAAGCTCTACCTTCC-30 and reverse 50-CAGGTCCACATGGTCTT
CCT-30; for TNFa, forward 50-CACGCTCTT-CTGCCTGCTG-30 and
reverse 50-GATGATCTGACTGCCTGGGC-30; for PTEN, forward 50- AA-
GACAAAGCCAACCGATAC-30 and reverse 50-GAAGTTGAACTG-
CTAGCCTC-30; for 18S rRNA, forward 50-CGGCTACCACATCCAAG-
GAA-30 and reverse 50-GCTGGAATTACC-GCGGCT-30.
Reference
1. Salati S, Zini R, Bianchi E, et al. Role of CD34 antigen in myeloid
differentiation of human hematopoietic progenitor cells. Stem Cells.
2008;26:950–959.
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Supplementary Table E1. GEO* accession numbers
Title (GEO) Accession no.
NB4_Untreated_1 GSM317352
NB4_Untreated_2 GSM317353
NB4_WEB2170_0.5 mM_24 hours_1 GSM317354
NB4_WEB2170_0.5 mM_24 hours_2 GSM317355
*Data from http://www.ncbi.nlm.nih.gov/geo
Supplementary Figure E1. Quantitative real-time polymerase chain
reaction analysis of PTEN expression in NB4 transfected with nontarget-
ing (control small interfering RNA [siRNA]) or PTEN-specific siRNA or
with nucleofactor solution alone (mock) and cultured in the presence or
absence of 0.5 mMWEB-2170 for 24 hours. Columns, average6 standard
deviation of three independent samples. Asterisk, significant difference
(***p! 0.001) from control.
1185.e2C. Cellai et al./ Experimental Hematology 2009;37:1176–1185
Supplementary Table E2. The list of 975 probesets modulated in WEB-2170 treated vs untreated NB4 cells
Probe set ID Gene symbol Gene title Average SLR
Representative
public ID
207156_at HIST1H2AG histone cluster 1, H2ag 4.95 NM_021064
221986_s_at KLHL24 kelch-like 24 (Drosophila) 4.03 AW006750
201325_s_at EMP1 epithelial membrane protein 1 3.98 NM_001423
210230_at LOC728965 Hypothetical protein LOC728965 3.93 BC003629
218087_s_at SORBS1 sorbin and SH3 domain containing 1 3.7 NM_015385
203271_s_at UNC119 unc-119 homolog (C. elegans) 3.6 NM_005148
213241_at PLXNC1 plexin C1 3.53 AF035307
201324_at EMP1 epithelial membrane protein 1 3.48 NM_001423
208791_at CLU clusterin 3.3 M25915
202770_s_at CCNG2 cyclin G2 3.25 NM_004354
210612_s_at SYNJ2 synaptojanin 2 3.25 AF318616
205352_at SERPINI1 serpin peptidase inhibitor, clade I (neuroserpin), member 1 3.23 NM_005025
202838_at FUCA1 fucosidase, alpha-L- 1, tissue 3.15 NM_000147
204174_at ALOX5AP arachidonate 5-lipoxygenase-activating protein 3.15 NM_001629
208965_s_at IFI16 interferon, gamma-inducible protein 16 3.15 BG256677
209684_at RIN2 Ras and Rab interactor 2 3.13 AL136924
204546_at KIAA0513 KIAA0513 3.1 NM_014732
205107_s_at EFNA4 ephrin-A4 3.03 NM_005227
207339_s_at LTB lymphotoxin beta (TNF superfamily, member 3) 3.03 NM_002341
212912_at RPS6KA2 ribosomal protein S6 kinase, 90 kDa, polypeptide 2 3.03 AI992251
204215_at C7orf23 chromosome 7 open reading frame 23 3 NM_024315
202769_at CCNG2 cyclin G2 2.95 AW134535
204081_at NRGN neurogranin (protein kinase C substrate, RC3) 2.9 NM_006176
204867_at GCHFR GTP cyclohydrolase I feedback regulator 2.9 NM_005258
201481_s_at PYGB phosphorylase, glycogen; brain 2.88 NM_002862
200762_at DPYSL2 dihydropyrimidinase-like 2 2.85 NM_001386
206332_s_at IFI16 interferon, gamma-inducible protein 16 2.85 NM_005531
208966_x_at IFI16 interferon, gamma-inducible protein 16 2.85 AF208043
202284_s_at CDKN1A cyclin-dependent kinase inhibitor 1A (p21, Cip1) 2.8 NM_000389
208792_s_at CLU clusterin 2.78 M25915
211559_s_at CCNG2 cyclin G2 2.73 L49506
204415_at IFI6 interferon, alpha-inducible protein 6 2.65 NM_022873
209154_at TAX1BP3 Tax1 (human T-cell leukemia virus type I) binding protein 3 2.65 AF234997
213479_at NPTX2 neuronal pentraxin II 2.65 U26662
209118_s_at TUBA3 tubulin, alpha 3 2.6 AF141347
214617_at PRF1 perforin 1 (pore forming protein) 2.6 AI445650
202478_at TRIB2 tribbles homolog 2 (Drosophila) 2.58 NM_021643
203827_at WIPI1 WD repeat domain, phosphoinositide interacting 1 2.58 NM_017983
205807_s_at TUFT1 tuftelin 1 2.5 NM_020127
218303_x_at KRCC1 lysine-rich coiled-coil 1 2.5 NM_016618
208949_s_at LGALS3 lectin, galactoside-binding, soluble, 3 (galectin 3) 2.43 BC001120
210130_s_at TM7SF2 transmembrane 7 superfamily member 2 2.43 AF096304
202479_s_at TRIB2 tribbles homolog 2 (Drosophila) 2.4 BC002637
215071_s_at HIST1H2AC histone cluster 1, H2ac 2.4 AL353759
202996_at POLD4 polymerase (DNA-directed), delta 4 2.38 NM_021173
220387_s_at HHLA3 HERV-H LTR-associating 3 2.38 NM_007071
222256_s_at PLA2G4B phospholipase A2, group IVB (cytosolic) 2.38 AK000550
205016_at TGFA transforming growth factor, alpha 2.35 NM_003236
207761_s_at METTL7A methyltransferase like 7A 2.35 NM_014033
209911_x_at HIST1H2BD histone cluster 1, H2bd 2.35 BC002842
204118_at CD48 CD48 molecule /// CD48 molecule 2.33 NM_001778
206110_at HIST1H3H histone cluster 1, H3 h 2.33 NM_003536
212195_at IL6ST Interleukin 6 signal transducer (gp130, oncostatin M receptor) 2.33 AL049265
212698_s_at 9/10 septin 10 2.33 BF966021
217979_at TSPAN13 Tetraspanin 13 2.33 NM_014399
204342_at SLC25A24 solute carrier family 25 (mitochondrial carrier; phosphate carrier),
member 24
2.3 NM_013386
222043_at CLU clusterin 2.3 AI982754
201739_at SGK serum/glucocorticoid regulated kinase 2.28 NM_005627
203845_at PCAF p300/CBP-associated factor 2.28 AV727449
(continued)
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208893_s_at DUSP6 dual specificity phosphatase 6 2.28 BC005047
210829_s_at SSBP2 single-stranded DNA binding protein 2 2.28 AF077048
202820_at AHR aryl hydrocarbon receptor 2.25 NM_001621
212886_at CCDC69 coiled-coil domain containing 69 2.25 AL080169
203787_at SSBP2 single-stranded DNA binding protein 2 2.23 NM_012446
209686_at S100B S100 calcium binding protein B 2.23 BC001766
213836_s_at WIPI1 WD repeat domain, phosphoinositide interacting 1 2.23 AW052084
201005_at CD9 CD9 molecule 2.18 NM_001769
202500_at DNAJB2 DnaJ (Hsp40) homolog, subfamily B, member 2 2.18 NM_006736
209102_s_at HBP1 HMG-box transcription factor 1 2.18 AF019214
212981_s_at KIAA0738 KIAA0738 gene product 2.18 BF030508
209683_at FAM49A family with sequence similarity 49, member A 2.15 AA243659
207194_s_at ICAM4 intercellular adhesion molecule 4 (Landsteiner-Wiener blood group) 2.13 NM_001544
208392_x_at SP110 SP110 nuclear body protein 2.13 NM_004510
214079_at DHRS2 dehydrogenase/reductase (SDR family) member 2 2.13 AK000345
41577_at PPP1R16B protein phosphatase 1, regulatory (inhibitor) subunit 16B 2.13 AB020630
201566_x_at ID2 /// ID2B inhibitor of DNA binding 2, dominant negative helix-loop-helix protein 2.1 D13891
204446_s_at ALOX5 arachidonate 5-lipoxygenase 2.1 NM_000698
213238_at ATP10D ATPase, Class V, type 10D 2.1 AI478147
218319_at PELI1 pellino homolog 1 (Drosophila) 2.1 NM_020651
221478_at BNIP3L BCL2/adenovirus E1B 19 kDa interacting protein 3-like 2.1 AL132665
201565_s_at ID2 inhibitor of DNA binding 2, dominant negative helix-loop-helix protein 2.08 NM_002166
204675_at SRD5A1 steroid-5-alpha-reductase, alpha polypeptide 1 (3-oxo-5 alpha-steroid
delta 4-dehydrogenase alpha 1)
2.08 NM_001047
209193_at PIM1 pim-1 oncogene 2.08 M24779
209427_at SMTN smoothelin 2.08 AF064238
212364_at MYO1B myosin IB 2.08 BF432550
200782_at ANXA5 annexin A5 2.05 NM_001154
203811_s_at DNAJB4 DnaJ (Hsp40) homolog, subfamily B, member 4 2.05 NM_007034
203680_at PRKAR2B protein kinase, cAMP-dependent, regulatory, type II, beta 2.03 NM_002736
214211_at FTH1 ferritin, heavy polypeptide 1 2.03 AA083483
217783_s_at YPEL5 yippee-like 5 (Drosophila) 2 NM_016061
204224_s_at GCH1 GTP cyclohydrolase 1 (dopa-responsive dystonia) 1.98 NM_000161
218304_s_at OSBPL11 oxysterol binding protein-like 11 1.95 NM_022776
201050_at PLD3 phospholipase D family, member 3 1.93 NM_012268
206471_s_at PLXNC1 plexin C1 1.93 NM_005761
208961_s_at KLF6 Kruppel-like factor 6 1.93 AB017493
210959_s_at SRD5A1 steroid-5-alpha-reductase, alpha polypeptide 1 (3-oxo-5 alpha-steroid
delta 4-dehydrogenase alpha 1)
1.93 AF113128
215464_s_at TAX1BP3 Tax1 (human T-cell leukemia virus type I) binding protein 3 1.93 AK001327
220974_x_at SFXN3 sideroflexin 3 1.93 NM_030971
202191_s_at GAS7 growth arrest-specific 7 1.9 BE439987
204859_s_at APAF1 apoptotic peptidase activating factor 1 1.9 NM_013229
214084_x_at ABR Active BCR-related gene 1.9 AW072388
214130_s_at PDE4DIP ///
LOC727942
phosphodiesterase 4D interacting protein (myomegalin) 1.9 AI821791
214720_x_at 9/10 septin 10 1.9 BF981643
217767_at LOC653879 similar to Complement C3 precursor 1.9 NM_000064
221599_at C11orf67 chromosome 11 open reading frame 67 1.9 BC002752
202437_s_at CYP1B1 cytochrome P450, family 1, subfamily B, polypeptide 1 1.88 NM_000104
218854_at SART2 squamous cell carcinoma antigen recognized by T cells 2 1.88 NM_013352
221618_s_at TAF9B ///
LOC728198
TAF9B RNA polymerase II, TATA box binding protein (TBP)-associated
factor, 31 kDa
1.88 AF220509
203946_s_at ARG2 arginase, type II 1.85 U75667
219489_s_at NXN nucleoredoxin 1.85 NM_017821
221664_s_at F11R F11 receptor 1.85 AF154005
39582_at CYLD cylindromatosis (turban tumor syndrome) 1.85 AL050166
204906_at RPS6KA2 ribosomal protein S6 kinase, 90 kDa, polypeptide 2 1.83 BC002363
211458_s_at GABARAPL1 ///
GABARAPL3
GABA(A) receptor-associated protein like 1 /// GABA(A) receptors
associated protein like 3
1.83 AF180519
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201467_s_at NQO1 NAD(P)H dehydrogenase, quinone 1 1.8 AI039874
221479_s_at BNIP3L BCL2/adenovirus E1B 19 kDa interacting protein 3-like 1.8 AF060922
201944_at HEXB hexosaminidase B (beta polypeptide) 1.78 NM_000521
202435_s_at CYP1B1 cytochrome P450, family 1, subfamily B, polypeptide 1 1.78 AU154504
203097_s_at RAPGEF2 Rap guanine nucleotide exchange factor (GEF) 2 1.78 NM_014247
213106_at — — 1.78 AI769688
218885_s_at GALNT12 UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-
acetylgalactosaminyltransferase 12 (GalNAc-T12)
1.78 NM_024642
220603_s_at MCTP2 multiple C2 domains, transmembrane 2 1.78 NM_018349
221600_s_at C11orf67 chromosome 11 open reading frame 67 1.78 BC002752
201236_s_at BTG2 BTG family, member 2 1.75 NM_006763
204451_at FZD1 frizzled homolog 1 (Drosophila) 1.75 NM_003505
205005_s_at NMT2 N-myristoyltransferase 2 1.75 AW293531
205441_at OCEL1 occludin/ELL domain containing 1 1.75 NM_024578
211056_s_at SRD5A1 steroid-5-alpha-reductase, alpha polypeptide 1 (3-oxo-5 alpha-
steroid delta 4-dehydrogenase alpha 1) /// steroid-5-alpha-reductase,
alpha polypeptide 1 (3-oxo-5 alpha-steroid delta 4-dehydrogenase
alpha 1)
1.75 BC006373
213463_s_at KIAA0974 KIAA0974 1.75 AW300504
201384_s_at NBR1 ///
LOC727732
neighbor of BRCA1 gene 1 /// similar to neighbor of BRCA1 gene 1 1.73 NM_005899
201468_s_at NQO1 NAD(P)H dehydrogenase, quinone 1 1.73 NM_000903
201613_s_at AP1G2 adaptor-related protein complex 1, gamma 2 subunit 1.73 BC000519
202942_at ETFB electron-transfer-flavoprotein, beta polypeptide 1.73 NM_001985
203300_x_at AP1S2 adaptor-related protein complex 1, sigma 2 subunit 1.73 NM_003916
207181_s_at CASP7 caspase 7, apoptosis-related cysteine peptidase 1.73 NM_001227
208436_s_at IRF7 interferon regulatory factor 7 1.73 NM_004030
212828_at SYNJ2 synaptojanin 2 1.73 AA191573
213906_at MYBL1 v-myb myeloblastosis viral oncogene homolog (avian)-like 1 1.73 AW592266
216041_x_at GRN granulin 1.73 AK023348
218217_at SCPEP1 serine carboxypeptidase 1 1.73 NM_021626
218656_s_at LHFP lipoma HMGIC fusion partner 1.73 NM_005780
218802_at CCDC109B coiled-coil domain containing 109B 1.73 NM_017918
221589_s_at ALDH6A1 aldehyde dehydrogenase 6 family, member A1 1.73 AW612403
202917_s_at S100A8 S100 calcium binding protein A8 1.7 NM_002964
203140_at BCL6 B-cell CLL/lymphoma 6 (zinc finger protein 51) 1.7 NM_001706
203855_at WDR47 WD repeat domain 47 1.7 NM_014969
208891_at DUSP6 dual specificity phosphatase 6 1.7 BC003143
209424_s_at AMACR alpha-methylacyl-CoA racemase 1.7 AI796120
210075_at 3/2 membrane-associated ring finger (C3HC4) 2 1.7 AF151074
212074_at UNC84A unc-84 homolog A (C. elegans) 1.7 BE972774
212509_s_at MXRA7 matrix-remodelling associated 7 1.7 BF968134
217226_s_at SFXN3 sideroflexin 3 1.7 M95929
201348_at GPX3 glutathione peroxidase 3 (plasma) 1.68 NM_002084
202436_s_at CYP1B1 cytochrome P450, family 1, subfamily B, polypeptide 1 1.68 AU144855
206542_s_at SMARCA2 SWI/SNF related, matrix associated, actin dependent regulator of
chromatin, subfamily a, member 2
1.68 AV725365
212979_s_at KIAA0738 KIAA0738 gene product 1.68 AW293343
218924_s_at CTBS chitobiase, di-N-acetyl- 1.68 NM_004388
219736_at TRIM36 tripartite motif-containing 36 1.68 NM_018700
221985_at KLHL24 kelch-like 24 (Drosophila) 1.68 AW006750
203227_s_at TSPAN31 tetraspanin 31 1.65 NM_005981
203409_at DDB2 damage-specific DNA binding protein 2, 48 kDa 1.65 NM_000107
208892_s_at DUSP6 dual specificity phosphatase 6 1.65 BC003143
213186_at DZIP3 zinc finger DAZ interacting protein 3 1.65 BG502305
219889_at FRAT1 frequently rearranged in advanced T-cell lymphomas 1.65 NM_005479
200678_x_at GRN granulin 1.63 NM_002087
201887_at IL13RA1 interleukin 13 receptor, alpha 1 1.63 NM_001560
203751_x_at JUND jun D proto-oncogene 1.63 AI762296
204882_at ARHGAP25 Rho GTPase activating protein 25 1.63 NM_014882
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206317_s_at ABCB8 ATP-binding cassette, sub-family B (MDR/TAP), member 8 1.63 NM_007188
208926_at NEU1 sialidase 1 (lysosomal sialidase) 1.63 U84246
213552_at GLCE UDP-glucuronic acid epimerase 1.63 W87398
218611_at IER5 immediate early response 5 1.63 NM_016545
202638_s_at ICAM1 intercellular adhesion molecule 1 (CD54), human rhinovirus receptor 1.6 NM_000201
202731_at PDCD4 programmed cell death 4 (neoplastic transformation inhibitor) 1.6 NM_014456
208944_at TGFBR2 transforming growth factor, beta receptor II (70/80 kDa) 1.6 D50683
210705_s_at TRIM5 tripartite motif-containing 5 1.6 AF220028
211284_s_at GRN granulin 1.6 BC000324
212990_at SYNJ1 synaptojanin 1 1.6 AB020717
215813_s_at PTGS1 prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and
cyclooxygenase)
1.6 S36219
218032_at SNN stannin 1.6 AF070673
218434_s_at AACS acetoacetyl-CoA synthetase 1.6 NM_023928
200904_at HLA-E major histocompatibility complex, class I, E 1.58 X56841
202275_at G6PD glucose-6-phosphate dehydrogenase 1.58 NM_000402
203411_s_at LMNA lamin A/C 1.58 NM_005572
204479_at OSTF1 osteoclast stimulating factor 1 1.58 NM_012383
211067_s_at GAS7 growth arrest-specific 7 1.58 BC006454
214259_s_at AKR7A2 aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase) 1.58 AI144075
217707_x_at SMARCA2 SWI/SNF related, matrix associated, actin dependent regulator of
chromatin, subfamily a, member 2
1.58 AI535683
221588_x_at ALDH6A1 aldehyde dehydrogenase 6 family, member A1 1.58 AI640855
56256_at SIDT2 SID1 transmembrane family, member 2 1.58 AA150165
200765_x_at CTNNA1 catenin (cadherin-associated protein), alpha 1, 102 kDa 1.55 NM_001903
200866_s_at PSAP prosaposin (variant Gaucher disease and variant metachromatic
leukodystrophy)
1.55 M32221
201581_at TXNDC13 thioredoxin domain containing 13 1.55 BF572868
204290_s_at ALDH6A1 aldehyde dehydrogenase 6 family, member A1 1.55 NM_005589
204912_at IL10RA interleukin 10 receptor, alpha 1.55 NM_001558
207467_x_at CAST calpastatin 1.55 NM_001750
212588_at PTPRC protein tyrosine phosphatase, receptor type, C 1.55 Y00062
212665_at TIPARP TCDD-inducible poly(ADP-ribose) polymerase 1.55 AL556438
212762_s_at TCF7L2 transcription factor 7-like 2 (T-cell specific, HMG-box) 1.55 AI375916
215111_s_at TSC22D1 TSC22 domain family, member 1 1.55 AK027071
202499_s_at SLC2A3 solute carrier family 2 (facilitated glucose transporter), member 3 1.53 NM_006931
204044_at QPRT quinolinate phosphoribosyltransferase (nicotinate-nucleotide
pyrophosphorylase (carboxylating))
1.53 NM_014298
205128_x_at PTGS1 prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and
cyclooxygenase)
1.53 NM_000962
207704_s_at GAS7 growth arrest-specific 7 1.53 NM_003644
208908_s_at CAST calpastatin 1.53 AF327443
213572_s_at SERPINB1 serpin peptidase inhibitor, clade B (ovalbumin), member 1 1.53 AI554300
213896_x_at KIAA0974 KIAA0974 1.53 BE856549
215235_at SPTAN1 spectrin, alpha, non-erythrocytic 1 (alpha-fodrin) 1.53 AL110273
218346_s_at SESN1 sestrin 1 1.53 NM_014454
32502_at GDPD5 glycerophosphodiester phosphodiesterase domain containing 5 1.53 AL041124
1729_at TRADD TNFRSF1A-associated via death domain 1.5 L41690
200899_s_at MGEA5 meningioma expressed antigen 5 (hyaluronidase) 1.5 NM_012215
202017_at EPHX1 epoxide hydrolase 1, microsomal (xenobiotic) 1.5 NM_000120
202022_at ALDOC aldolase C, fructose-bisphosphate 1.5 NM_005165
202748_at GBP2 guanylate binding protein 2, interferon-inducible 1.5 NM_004120
202814_s_at HEXIM1 hexamethylene bis-acetamide inducible 1 1.5 AW193511
204759_at RCBTB2 regulator of chromosome condensation (RCC1) and BTB (POZ) domain
containing protein 2
1.5 NM_001268
205006_s_at NMT2 N-myristoyltransferase 2 1.5 NM_004808
207390_s_at SMTN smoothelin 1.5 NM_006932
218487_at ALAD aminolevulinate, delta-, dehydratase 1.5 BC000977
219843_at IPP intracisternal A particle-promoted polypeptide 1.5 NM_005897
200701_at NPC2 Niemann-Pick disease, type C2 1.48 NM_006432
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202452_at ZYG11BL zyg-11 homolog B (C. elegans)-like 1.48 AI991574
203651_at ZFYVE16 zinc finger, FYVE domain containing 16 1.48 NM_014733
204059_s_at ME1 malic enzyme 1, NADP(þ)-dependent, cytosolic 1.48 NM_002395
209019_s_at PINK1 PTEN induced putative kinase 1 1.48 AF316873
209531_at GSTZ1 glutathione transferase zeta 1 (maleylacetoacetate isomerase) 1.48 BC001453
212365_at MYO1B myosin IB 1.48 BF215996
218559_s_at MAFB v-maf musculoaponeurotic fibrosarcoma oncogene homolog B (avian) 1.48 NM_005461
201760_s_at WSB2 WD repeat and SOCS box-containing 2 1.45 NM_018639
202388_at RGS2 regulator of G-protein signalling 2, 24 kDa 1.45 NM_002923
203607_at INPP5F inositol polyphosphate-5-phosphatase F 1.45 NM_014937
206544_x_at SMARCA2 SWI/SNF related, matrix associated, actin dependent regulator
of chromatin, subfamily a, member 2
1.45 NM_003070
212268_at SERPINB1 serpin peptidase inhibitor, clade B (ovalbumin), member 1 1.45 NM_030666
212346_s_at MXD4 MAX dimerization protein 4 1.45 AK026392
212586_at CAST calpastatin 1.45 AA195244
200958_s_at SDCBP syndecan binding protein (syntenin) 1.43 NM_005625
201888_s_at IL13RA1 interleukin 13 receptor, alpha 1 1.43 U81379
202743_at PIK3R3 phosphoinositide-3-kinase, regulatory subunit 3 (p55, gamma) 1.43 BE622627
203186_s_at S100A4 S100 calcium binding protein A4 1.43 NM_002961
203567_s_at TRIM38 tripartite motif-containing 38 1.43 AU157590
203688_at PKD2 polycystic kidney disease 2 (autosomal dominant) 1.43 NM_000297
205047_s_at ASNS asparagine synthetase 1.43 NM_001673
209043_at PAPSS1 3’-phosphoadenosine 5’-phosphosulfate synthase 1 1.43 AF033026
209426_s_at AMACR alpha-methylacyl-CoA racemase 1.43 AF047020
210054_at C4orf15 chromosome 4 open reading frame 15 1.43 BC003648
212870_at RASSF3 Ras association (RalGDS/AF-6) domain family 3 1.43 AI628605
212989_at TMEM23 transmembrane protein 23 1.43 AI377497
218923_at CTBS chitobiase, di-N-acetyl- 1.43 AW304174
218930_s_at TMEM106B transmembrane protein 106B 1.43 NM_018374
221718_s_at AKAP13 A kinase (PRKA) anchor protein 13 /// A kinase (PRKA) anchor
protein 13
1.43 M90360
221903_s_at CYLD cylindromatosis (turban tumor syndrome) 1.43 BE046443
222088_s_at SLC2A3 solute carrier family 2 (facilitated glucose transporter), member 3 1.43 AA778684
205486_at TESK2 testis-specific kinase 2 1.4 NM_007170
208611_s_at SPTAN1 spectrin, alpha, non-erythrocytic 1 (alpha-fodrin) 1.4 U83867
212274_at LPIN1 lipin 1 1.4 AV705559
212299_at NEK9 NIMA (never in mitosis gene a)- related kinase 9 1.4 AL117502
38149_at ARHGAP25 Rho GTPase activating protein 25 1.4 D29642
201648_at JAK1 Janus kinase 1 (a protein tyrosine kinase) 1.38 AL039831
202338_at TK1 thymidine kinase 1, soluble 1.38 NM_003258
202880_s_at PSCD1 pleckstrin homology, Sec7 and coiled-coil domains 1(cytohesin 1) 1.38 NM_004762
203262_s_at FAM50A family with sequence similarity 50, member A 1.38 NM_004699
203538_at CAMLG ///
FAM39DP
calcium modulating ligand /// family with sequence similarity 39,
member D pseudogene
1.38 NM_001745
204076_at ENTPD4 ectonucleoside triphosphate diphosphohydrolase 4 1.38 AB002390
204279_at PSMB9 proteasome (prosome, macropain) subunit, beta type, 9 (large
multifunctional peptidase 2)
1.38 NM_002800
205315_s_at SNTB2 syntrophin, beta 2 (dystrophin-associated protein A1, 59 kDa, basic
component 2)
1.38 NM_006750
206222_at TNFRSF10C tumor necrosis factor receptor superfamily, member 10c, decoy
without an intracellular domain
1.38 NM_003841
209463_s_at TAF12 TAF12 RNA polymerase II, TATA box binding protein (TBP)-associated
factor, 20 kDa
1.38 D50544
210872_x_at GAS7 growth arrest-specific 7 1.38 BC001152
213057_at ATPAF2 ATP synthase mitochondrial F1 complex assembly factor 2 1.38 AW118608
214121_x_at PDLIM7 PDZ and LIM domain 7 (enigma) 1.38 AA086229
200905_x_at HLA-E major histocompatibility complex, class I, E 1.35 NM_005516
201009_s_at TXNIP thioredoxin interacting protein 1.35 AI439556
201015_s_at JUP junction plakoglobin 1.35 NM_021991
202139_at AKR7A2 aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase) 1.35 NM_003689
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203445_s_at CTDSP2 CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A)
small phosphatase 2
1.35 NM_005730
203695_s_at DFNA5 deafness, autosomal dominant 5 1.35 NM_004403
204340_at CXorf12 chromosome X open reading frame 12 1.35 NM_003492
205786_s_at ITGAM integrin, alpha M (complement component 3 receptor 3 subunit) ///
integrin, alpha M (complement component 3 receptor 3 subunit)
1.35 NM_000632
209513_s_at HSDL2 hydroxysteroid dehydrogenase like 2 1.35 BC004331
218384_at CARHSP1 calcium regulated heat stable protein 1, 24 kDa 1.35 NM_014316
219147_s_at C9orf95 chromosome 9 open reading frame 95 1.35 NM_017881
219210_s_at RAB8B RAB8B, member RAS oncogene family 1.35 NM_016530
200871_s_at PSAP prosaposin (variant Gaucher disease and variant metachromatic
leukodystrophy)
1.33 NM_002778
202660_at ITPR2 inositol 1,4,5-triphosphate receptor, type 2 1.33 AA834576
202801_at PRKACA protein kinase, cAMP-dependent, catalytic, alpha 1.33 NM_002730
203741_s_at ADCY7 adenylate cyclase 7 1.33 NM_001114
204205_at APOBEC3 G apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3 G 1.33 NM_021822
209006_s_at C1orf63 chromosome 1 open reading frame 63 1.33 AF247168
209295_at TNFRSF10B tumor necrosis factor receptor superfamily, member 10b 1.33 AF016266
209875_s_at SPP1 secreted phosphoprotein 1 (osteopontin, bone sialoprotein I, early
T-lymphocyte activation 1)
1.33 M83248
210778_s_at MXD4 MAX dimerization protein 4 1.33 BC002713
210844_x_at CTNNA1 catenin (cadherin-associated protein), alpha 1, 102 kDa 1.33 D14705
211711_s_at PTEN phosphatase and tensin homolog (mutated in multiple advanced cancers 1) 1.33 BC005821
212944_at SLC5A3 solute carrier family 5 (inositol transporters), member 3 1.33 AK024896
217513_at C17orf60 chromosome 17 open reading frame 60 1.33 BG334495
219487_at BBS10 Bardet-Biedl syndrome 10 1.33 NM_024685
219691_at SAMD9 sterile alpha motif domain containing 9 1.33 NM_017654
220999_s_at CYFIP2 cytoplasmic FMR1 interacting protein 2 1.33 NM_030778
200748_s_at FTH1 ferritin, heavy polypeptide 1 1.3 NM_002032
201132_at HNRPH2 heterogeneous nuclear ribonucleoprotein H2 (H’) 1.3 NM_019597
201845_s_at RYBP RING1 and YY1 binding protein 1.3 AB029551
203179_at GALT /// C10orf4 galactose-1-phosphate uridylyltransferase /// chromosome 10 open
reading frame 4
1.3 NM_000155
203457_at STX7 syntaxin 7 1.3 NM_003569
204286_s_at PMAIP1 phorbol-12-myristate-13-acetate-induced protein 1 1.3 NM_021127
204484_at PIK3C2B phosphoinositide-3-kinase, class 2, beta polypeptide 1.3 NM_002646
205804_s_at TRAF3IP3 TRAF3 interacting protein 3 1.3 NM_025228
207113_s_at TNF tumor necrosis factor (TNF superfamily, member 2) 1.3 NM_000594
207238_s_at PTPRC protein tyrosine phosphatase, receptor type, C 1.3 NM_002838
209298_s_at ITSN1 intersectin 1 (SH3 domain protein) 1.3 AF114488
212086_x_at LMNA lamin A/C 1.3 AK026584
212594_at PDCD4 programmed cell death 4 (neoplastic transformation inhibitor) 1.3 AI185160
212631_at STX7 Syntaxin 7 1.3 AI566082
217744_s_at PERP PERP, TP53 apoptosis effector 1.3 NM_022121
221752_at SSH1 Slingshot homolog 1 (Drosophila) 1.3 AL041728
200921_s_at BTG1 B-cell translocation gene 1, anti-proliferative 1.28 NM_001731
202351_at ITGAV integrin, alpha V (vitronectin receptor, alpha polypeptide, antigen CD51) 1.28 AI093579
202501_at MAPRE2 microtubule-associated protein, RP/EB family, member 2 1.28 NM_014268
202730_s_at PDCD4 programmed cell death 4 (neoplastic transformation inhibitor) 1.28 NM_014456
202772_at HMGCL 3-hydroxymethyl-3-methylglutaryl-Coenzyme A lyase
(hydroxymethylglutaricaciduria)
1.28 NM_000191
203778_at MANBA mannosidase, beta A, lysosomal 1.28 NM_005908
203912_s_at DNASE1L1 deoxyribonuclease I-like 1 1.28 NM_006730
204058_at ME1 malic enzyme 1, NADP(þ)-dependent, cytosolic 1.28 AL049699
204805_s_at H1FX H1 histone family, member X 1.28 NM_006026
205091_x_at RECQL RecQ protein-like (DNA helicase Q1-like) 1.28 NM_002907
209028_s_at ABI1 abl-interactor 1 1.28 AF006516
209585_s_at MINPP1 multiple inositol polyphosphate histidine phosphatase, 1 1.28 AF084943
210519_s_at NQO1 NAD(P)H dehydrogenase, quinone 1 1.28 BC000906
210980_s_at ASAH1 N-acylsphingosine amidohydrolase (acid ceramidase) 1 1.28 U47674
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212276_at LPIN1 lipin 1 1.28 D80010
212587_s_at PTPRC protein tyrosine phosphatase, receptor type, C 1.28 AI809341
212917_x_at RECQL RecQ protein-like (DNA helicase Q1-like) 1.28 AI814728
214091_s_at GPX3 glutathione peroxidase 3 (plasma) 1.28 AW149846
215017_s_at FNBP1L formin binding protein 1-like 1.28 AW270932
218195_at C6orf211 chromosome 6 open reading frame 211 1.28 NM_024573
218231_at NAGK N-acetylglucosamine kinase /// N-acetylglucosamine kinase 1.28 NM_017567
218992_at C9orf46 chromosome 9 open reading frame 46 1.28 NM_018465
49679_s_at MMP24 Matrix metallopeptidase 24 (membrane-inserted) 1.28 AA243774
200632_s_at NDRG1 N-myc downstream regulated gene 1 1.25 NM_006096
200764_s_at CTNNA1 catenin (cadherin-associated protein), alpha 1, 102 kDa 1.25 AI826881
202192_s_at GAS7 growth arrest-specific 7 1.25 NM_005890
202887_s_at DDIT4 DNA-damage-inducible transcript 4 1.25 NM_019058
203085_s_at TGFB1 transforming growth factor, beta 1 (Camurati-Engelmann disease) 1.25 BC000125
204333_s_at AGA aspartylglucosaminidase 1.25 NM_000027
208012_x_at SP110 SP110 nuclear body protein 1.25 NM_004509
208092_s_at FAM49A family with sequence similarity 49, member A 1.25 NM_030797
209379_s_at KIAA1128 KIAA1128 1.25 AF241785
209425_at AMACR alpha-methylacyl-CoA racemase 1.25 AA888589
210240_s_at CDKN2D cyclin-dependent kinase inhibitor 2D (p19, inhibits CDK4) 1.25 U20498
212632_at STX7 Syntaxin 7 1.25 N32035
214326_x_at JUND jun D proto-oncogene 1.25 AI339541
214639_s_at HOXA1 homeobox A1 1.25 S79910
215936_s_at KIAA1033 KIAA1033 1.25 AK001657
216060_s_at DAAM1 dishevelled associated activator of morphogenesis 1 1.25 AK021890
216064_s_at AGA aspartylglucosaminidase 1.25 W27131
218477_at TMEM14A transmembrane protein 14A 1.25 NM_014051
218676_s_at PCTP phosphatidylcholine transfer protein 1.25 NM_021213
219099_at C12orf5 chromosome 12 open reading frame 5 1.25 NM_020375
200761_s_at ARL6IP5 ADP-ribosylation-like factor 6 interacting protein 5 1.23 NM_006407
202704_at TOB1 transducer of ERBB2, 1 1.23 AA675892
203132_at RB1 retinoblastoma 1 (including osteosarcoma) 1.23 NM_000321
204232_at FCER1 G Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide 1.23 NM_004106
204480_s_at C9orf16 chromosome 9 open reading frame 16 1.23 NM_024112
209345_s_at PI4KII phosphatidylinositol 4-kinase type II 1.23 AL561930
210202_s_at BIN1 bridging integrator 1 1.23 U87558
210568_s_at RECQL RecQ protein-like (DNA helicase Q1-like) 1.23 BC001052
212750_at PPP1R16B protein phosphatase 1, regulatory (inhibitor) subunit 16B 1.23 AB020630
218628_at CCDC53 coiled-coil domain containing 53 1.23 NM_016053
200920_s_at BTG1 B-cell translocation gene 1, anti-proliferative 1.2 AL535380
201008_s_at TXNIP thioredoxin interacting protein 1.2 AA812232
202439_s_at IDS iduronate 2-sulfatase (Hunter syndrome) 1.2 NM_000202
202891_at NIT1 nitrilase 1 1.2 NM_005600
203080_s_at BAZ2B bromodomain adjacent to zinc finger domain, 2B 1.2 NM_013450
203568_s_at TRIM38 tripartite motif-containing 38 1.2 NM_006355
204362_at SKAP2 src kinase associated phosphoprotein 2 1.2 NM_003930
208786_s_at MAP1LC3B microtubule-associated protein 1 light chain 3 beta 1.2 AF183417
209417_s_at IFI35 interferon-induced protein 35 1.2 BC001356
209575_at IL10RB interleukin 10 receptor, beta 1.2 BC001903
209806_at HIST1H2BK histone cluster 1, H2bk 1.2 BC000893
212229_s_at FBXO21 F-box protein 21 1.2 AK001699
212359_s_at KIAA0913 KIAA0913 1.2 W89120
218218_at DIP13B DIP13 beta 1.2 NM_018171
201349_at SLC9A3R1 solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulator 1 1.18 NM_004252
201580_s_at TXNDC13 thioredoxin domain containing 13 1.18 AL544094
201805_at PRKAG1 protein kinase, AMP-activated, gamma 1 non-catalytic subunit 1.18 NM_002733
202637_s_at ICAM1 intercellular adhesion molecule 1 (CD54), human rhinovirus receptor 1.18 AI608725
204201_s_at PTPN13 protein tyrosine phosphatase, non-receptor type 13 (APO-1/CD95 (Fas)-
associated phosphatase)
1.18 NM_006264
204526_s_at TBC1D8 TBC1 domain family, member 8 (with GRAM domain) 1.18 NM_007063
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204873_at PEX1 peroxisome biogenesis factor 1 1.18 NM_000466
207001_x_at TSC22D3 TSC22 domain family, member 3 1.18 NM_004089
208763_s_at TSC22D3 TSC22 domain family, member 3 1.18 AL110191
212530_at NEK7 NIMA (never in mitosis gene a)-related kinase 7 1.18 AL080111
212675_s_at — — 1.18 AB011154
212794_s_at KIAA1033 KIAA1033 1.18 AK001728
213271_s_at DOPEY1 dopey family member 1 1.18 AB029040
218248_at FAM111A family with sequence similarity 111, member A 1.18 NM_022074
218273_s_at PPM2C protein phosphatase 2C, magnesium-dependent, catalytic subunit 1.18 NM_018444
220775_s_at UEVLD UEV and lactate/malate dehyrogenase domains 1.18 NM_018314
221059_s_at COTL1 coactosin-like 1 (Dictyostelium) 1.18 NM_021615
221590_s_at ALDH6A1 Aldehyde dehydrogenase 6 family, member A1 1.18 AF130089
36553_at ASMTL acetylserotonin O-methyltransferase-like 1.18 AA669799
200847_s_at TMEM66 transmembrane protein 66 1.15 NM_016127
201383_s_at NBR1 ///
LOC727732
neighbor of BRCA1 gene 1 /// similar to neighbor of BRCA1 gene 1 1.15 AL044170
201811_x_at SH3BP5 SH3-domain binding protein 5 (BTK-associated) 1.15 NM_004844
203984_s_at CASP9 caspase 9, apoptosis-related cysteine peptidase 1.15 U60521
204068_at STK3 serine/threonine kinase 3 (STE20 homolog, yeast) 1.15 NM_006281
205263_at BCL10 B-cell CLL/lymphoma 10 1.15 AF082283
205434_s_at AAK1 ///
LOC647217
AP2 associated kinase 1 /// hypothetical protein LOC647217 1.15 AW451954
209512_at HSDL2 hydroxysteroid dehydrogenase like 2 1.15 BC004331
210410_s_at MSH5 mutS homolog 5 (E. coli) 1.15 AF034759
212593_s_at PDCD4 programmed cell death 4 (neoplastic transformation inhibitor) 1.15 N92498
212918_at RECQL RecQ protein-like (DNA helicase Q1-like) 1.15 AI962943
214439_x_at BIN1 bridging integrator 1 1.15 AF043899
216080_s_at FADS3 fatty acid desaturase 3 1.15 AC004770
218208_at PQLC1 PQ loop repeat containing 1 1.15 NM_025078
218376_s_at MICAL1 microtubule associated monoxygenase, calponin and LIM domain
containing 1
1.15 NM_022765
219681_s_at RAB11FIP1 RAB11 family interacting protein 1 (class I) 1.15 NM_025151
222217_s_at SLC27A3 solute carrier family 27 (fatty acid transporter), member 3 1.15 BC003654
41047_at C9orf16 chromosome 9 open reading frame 16 1.15 AI885170
43427_at ACACB acetyl-Coenzyme A carboxylase beta 1.15 AI970898
213373_s_at CASP8 caspase 8, apoptosis-related cysteine peptidase 1.13 BF439983
200898_s_at MGEA5 meningioma expressed antigen 5 (hyaluronidase) 1.13 AK002091
201118_at PGD /// UGDH phosphogluconate dehydrogenase /// UDP-glucose dehydrogenase 1.13 NM_002631
201847_at LIPA lipase A, lysosomal acid, cholesterol esterase (Wolman disease) 1.13 NM_000235
202239_at PARP4 poly (ADP-ribose) polymerase family, member 4 1.13 NM_006437
202260_s_at STXBP1 syntaxin binding protein 1 1.13 NM_003165
202498_s_at SLC2A3 solute carrier family 2 (facilitated glucose transporter), member 3 1.13 BE550486
202533_s_at DHFR ///
LOC643509
dihydrofolate reductase /// similar to Dihydrofolate reductase 1.13 BC003584
202609_at EPS8 epidermal growth factor receptor pathway substrate 8 1.13 NM_004447
202677_at RASA1 RAS p21 protein activator (GTPase activating protein) 1 1.13 NM_002890
202931_x_at BIN1 bridging integrator 1 1.13 NM_004305
204091_at PDE6D phosphodiesterase 6D, cGMP-specific, rod, delta 1.13 NM_002601
204131_s_at FOXO3A forkhead box O3A 1.13 N25732
204222_s_at GLIPR1 GLI pathogenesis-related 1 (glioma) 1.13 NM_006851
204917_s_at MLLT3 myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog,
Drosophila); translocated to, 3
1.13 AV756536
204918_s_at MLLT3 myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog,
Drosophila); translocated to, 3
1.13 NM_004529
207677_s_at NCF4 neutrophil cytosolic factor 4, 40 kDa /// neutrophil cytosolic factor
4, 40 kDa
1.13 NM_013416
209457_at DUSP5 dual specificity phosphatase 5 1.13 U16996
209761_s_at SP110 SP110 nuclear body protein 1.13 AA969194
209799_at PRKAA1 protein kinase, AMP-activated, alpha 1 catalytic subunit 1.13 AF100763
212457_at TFE3 transcription factor binding to IGHM enhancer 3 1.13 AL161985
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212872_s_at TRFP Trf (TATA binding protein-related factor)-proximal homolog
(Drosophila)
1.13 AK023092
216381_x_at AKR7A3 aldo-keto reductase family 7, member A3 (aflatoxin aldehyde reductase) 1.13 AL035413
218191_s_at LMBRD1 LMBR1 domain containing 1 1.13 NM_018368
218450_at HEBP1 heme binding protein 1 1.13 NM_015987
218688_at DAK dihydroxyacetone kinase 2 homolog (S. cerevisiae) 1.13 NM_015533
221563_at DUSP10 dual specificity phosphatase 10 1.13 N36770
40420_at STK10 serine/threonine kinase 10 1.13 AB015718
200885_at RHOC ras homolog gene family, member C 1.1 NM_005167
202693_s_at STK17A serine/threonine kinase 17a (apoptosis-inducing) 1.1 AW194730
203810_at DNAJB4 DnaJ (Hsp40) homolog, subfamily B, member 4 1.1 BG252490
203814_s_at NQO2 NAD(P)H dehydrogenase, quinone 2 1.1 NM_000904
207700_s_at NCOA3 nuclear receptor coactivator 3 1.1 NM_006534
209605_at TST thiosulfate sulfurtransferase (rhodanese) 1.1 D87292
209649_at STAM2 signal transducing adaptor molecule (SH3 domain and ITAM motif) 2 1.1 AL133600
212646_at RFTN1 raftlin, lipid raft linker 1 1.1 D42043
212795_at KIAA1033 KIAA1033 1.1 AL137753
213164_at SLC5A3 solute carrier family 5 (inositol transporters), member 3 1.1 AI867198
213295_at CYLD cylindromatosis (turban tumor syndrome) 1.1 AA555096
214683_s_at CLK1 CDC-like kinase 1 1.1 AI251890
215127_s_at RBMS1 RNA binding motif, single stranded interacting protein 1 1.1 AL517946
215884_s_at UBQLN2 ubiquilin 2 1.1 AK001029
216511_s_at TCF7L2 transcription factor 7-like 2 (T-cell specific, HMG-box) 1.1 AJ270770
216860_s_at GDF11 growth differentiation factor 11 1.1 AF028333
216899_s_at SKAP2 src kinase associated phosphoprotein 2 1.1 AC003999
217868_s_at METTL9 methyltransferase like 9 1.1 NM_016025
218342_s_at KIAA1815 KIAA1815 1.1 NM_024896
218773_s_at MSRB2 methionine sulfoxide reductase B2 1.1 NM_012228
35254_at TRAFD1 TRAF-type zinc finger domain containing 1 1.1 AB007447
200931_s_at VCL vinculin 1.08 NM_014000
200974_at ACTA2 actin, alpha 2, smooth muscle, aorta 1.08 NM_001613
201012_at ANXA1 annexin A1 1.08 NM_000700
202446_s_at PLSCR1 phospholipid scramblase 1 1.08 AI825926
202625_at LYN v-yes-1 Yamaguchi sarcoma viral related oncogene homolog 1.08 AI356412
202808_at — — 1.08 AK000161
202888_s_at ANPEP alanyl (membrane) aminopeptidase (aminopeptidase N, aminopeptidase
M, microsomal aminopeptidase, CD13, p150)
1.08 NM_001150
204141_at TUBB2A tubulin, beta 2A 1.08 NM_001069
205546_s_at TYK2 tyrosine kinase 2 1.08 NM_003331
209536_s_at EHD4 EH-domain containing 4 1.08 AF320070
209715_at CBX5 chromobox homolog 5 (HP1 alpha homolog, Drosophila) 1.08 L07515
210276_s_at TRIOBP TRIO and F-actin binding protein 1.08 AF281030
211552_s_at ALDH4A1 aldehyde dehydrogenase 4 family, member A1 1.08 U24267
212189_s_at COG4 component of oligomeric golgi complex 4 1.08 AK022874
212347_x_at MXD4 MAX dimerization protein 4 1.08 AA831438
212633_at KIAA0776 KIAA0776 1.08 AL132776
212697_at LOC162427 hypothetical protein LOC162427 1.08 AL515874
212792_at DPY19L1 dpy-19-like 1 (C. elegans) 1.08 AB020684
214274_s_at ACAA1 acetyl-Coenzyme A acyltransferase 1 (peroxisomal 3-oxoacyl-Coenzyme
A thiolase)
1.08 AI860341
214703_s_at MAN2B2 mannosidase, alpha, class 2B, member 2 1.08 AW954107
217996_at PHLDA1 pleckstrin homology-like domain, family A, member 1 1.08 AA576961
218418_s_at ANKRD25 ankyrin repeat domain 25 1.08 NM_015493
219297_at WDR44 WD repeat domain 44 1.08 NM_019045
201010_s_at TXNIP thioredoxin interacting protein 1.05 NM_006472
201502_s_at NFKBIA nuclear factor of kappa light polypeptide gene enhancer in B-cells
inhibitor, alpha
1.05 AI078167
201719_s_at EPB41L2 erythrocyte membrane protein band 4.1-like 2 1.05 NM_001431
201972_at ATP6V1A ATPase, Hþ transporting, lysosomal 70 kDa, V1 subunit A 1.05 AF113129
202561_at TNKS tankyrase, TRF1-interacting ankyrin-related ADP-ribose polymerase 1.05 AF070613
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203303_at DYNLT3 dynein, light chain, Tctex-type 3 1.05 NM_006520
203739_at ZNF217 zinc finger protein 217 1.05 NM_006526
204094_s_at TSC22D2 TSC22 domain family, member 2 1.05 NM_014779
208785_s_at MAP1LC3B microtubule-associated protein 1 light chain 3 beta 1.05 BE893893
208796_s_at CCNG1 cyclin G1 1.05 BC000196
209027_s_at ABI1 abl-interactor 1 1.05 BF673013
209113_s_at HMG20B high-mobility group 20B 1.05 AF288679
209234_at KIF1B kinesin family member 1B 1.05 BF939474
213300_at KIAA0404 hypothetical protein LOC23130 1.05 AW168132
213471_at NPHP4 nephronophthisis 4 1.05 AB014573
213485_s_at ABCC10 ATP-binding cassette, sub-family C (CFTR/MRP), member 10 1.05 AK000002
213578_at BMPR1A bone morphogenetic protein receptor, type IA 1.05 AI678679
217967_s_at FAM129A family with sequence similarity 129, member A 1.05 AF288391
218456_at C1QDC1 C1q domain containing 1 1.05 NM_023925
219349_s_at EXOC2 exocyst complex component 2 1.05 NM_018303
219351_at TRAPPC2 trafficking protein particle complex 2 1.05 NM_014563
220162_s_at CARD9 caspase recruitment domain family, member 9 1.05 NM_022352
221561_at SOAT1 sterol O-acyltransferase (acyl-Coenzyme A: cholesterol acyltransferase) 1 1.05 L21934
221922_at GPSM2 G-protein signalling modulator 2 (AGS3-like, C. elegans) 1.05 AW195581
78047_s_at LOC729580 ///
LOC730672
hypothetical protein LOC729580 /// hypothetical protein LOC730672 1.05 AW001777
200791_s_at IQGAP1 IQ motif containing GTPase activating protein 1 1.03 NM_003870
202131_s_at RIOK3 RIO kinase 3 (yeast) /// RIO kinase 3 (yeast) 1.03 NM_003831
202203_s_at AMFR autocrine motility factor receptor 1.03 NM_001144
202213_s_at CUL4B cullin 4B 1.03 AI650819
202214_s_at CUL4B cullin 4B 1.03 NM_003588
202679_at NPC1 Niemann-Pick disease, type C1 1.03 NM_000271
202922_at GCLC glutamate-cysteine ligase, catalytic subunit 1.03 BF676980
203047_at STK10 serine/threonine kinase 10 1.03 NM_005990
203474_at IQGAP2 IQ motif containing GTPase activating protein 2 1.03 NM_006633
203481_at C10orf6 chromosome 10 open reading frame 6 1.03 AI655902
204054_at PTEN phosphatase and tensin homolog (mutated in multiple advanced cancers 1) 1.03 NM_000314
205147_x_at NCF4 neutrophil cytosolic factor 4, 40 kDa 1.03 NM_000631
209553_at VPS8 vacuolar protein sorting 8 homolog (S. cerevisiae) 1.03 BC001001
210201_x_at BIN1 bridging integrator 1 1.03 AF001383
210312_s_at IFT20 intraflagellar transport 20 homolog (Chlamydomonas) 1.03 BC002640
212111_at STX12 syntaxin 12 1.03 AA628051
212126_at — CDNA clone IMAGE:4842353 1.03 BG391282
212423_at C10orf56 chromosome 10 open reading frame 56 1.03 AK024784
212677_s_at CEP68 centrosomal protein 68 kDa 1.03 BG530481
212877_at KNS2 kinesin 2 1.03 AA284075
212899_at CDC2L6 cell division cycle 2-like 6 (CDK8-like) 1.03 AB028951
214266_s_at PDLIM7 PDZ and LIM domain 7 (enigma) 1.03 AW206786
216033_s_at FYN FYN oncogene related to SRC, FGR, YES 1.03 S74774
218124_at RETSAT retinol saturase (all-trans-retinol 13,14-reductase) 1.03 NM_017750
218813_s_at SH3GLB2 SH3-domain GRB2-like endophilin B2 1.03 NM_020145
64486_at CORO1B coronin, actin binding protein, 1B 1.03 AI341234
200872_at S100A10 S100 calcium binding protein A10 1 NM_002966
201482_at QSCN6 quiescin Q6 1 NM_002826
201734_at CLCN3 Chloride channel 3 1 AI760629
201753_s_at ADD3 adducin 3 (gamma) 1 NM_019903
203310_at STXBP3 syntaxin binding protein 3 1 NM_007269
203752_s_at JUND jun D proto-oncogene 1 NM_005354
204703_at IFT88 intraflagellar transport 88 homolog (Chlamydomonas) 1 NM_006531
205191_at RP2 retinitis pigmentosa 2 (X-linked recessive) 1 NM_006915
208546_x_at HIST1H2BH histone cluster 1, H2bh 1 NM_003524
208671_at SERINC1 serine incorporator 1 1 AF164794
208723_at USP11 ubiquitin specific peptidase 11 1 BC000350
209112_at CDKN1B cyclin-dependent kinase inhibitor 1B (p27, Kip1) 1 BC001971
211676_s_at IFNGR1 interferon gamma receptor 1 /// interferon gamma receptor 1 1 AF056979
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212919_at DCP2 DCP2 decapping enzyme homolog (S. cerevisiae) 1 AV715578
213000_at MORC3 MORC family CW-type zinc finger 3 1 AP000693
213275_x_at CTSB cathepsin B 1 W47179
214909_s_at DDAH2 dimethylarginine dimethylaminohydrolase 2 1 AK026191
216250_s_at LPXN leupaxin 1 X77598
217731_s_at ITM2B integral membrane protein 2B 1 NM_021999
217733_s_at TMSB10 thymosin, beta 10 1 NM_021103
217973_at DCXR dicarbonyl/L-xylulose reductase 1 NM_016286
219201_s_at TWSG1 twisted gastrulation homolog 1 (Drosophila) 1 NM_020648
221613_s_at ZFAND6 zinc finger, AN1-type domain 6 1 AL136598
221897_at TRIM52 tripartite motif-containing 52 1 AA205660
222165_x_at C9orf16 chromosome 9 open reading frame 16 1 AK022885
37590_g_at ZNF710 ///
DOCK4
Zinc finger protein 710 /// MRNA full length insert cDNA clone
EUROIMAGE 375854 /// Dedicator of cytokinesis 4
1 AL109698
200670_at XBP1 X-box binding protein 1 1 NM_005080
201389_at ITGA5 integrin, alpha 5 (fibronectin receptor, alpha polypeptide) 1 NM_002205
201420_s_at WDR77 WD repeat domain 77 1 BF975273
201675_at AKAP1 A kinase (PRKA) anchor protein 1 1 NM_003488
201872_s_at ABCE1 ATP-binding cassette, sub-family E (OABP), member 1 1 AI002002
202915_s_at FAM20B family with sequence similarity 20, member B 1 BF115776
202937_x_at CTA-126B4.3 CGI-96 protein 1 AL022316
203408_s_at SATB1 special AT-rich sequence binding protein 1 (binds to nuclear matrix/
scaffold-associating DNA’s)
1 NM_002971
204033_at TRIP13 thyroid hormone receptor interactor 13 1 NM_004237
207515_s_at POLR1C polymerase (RNA) I polypeptide C, 30 kDa 1 NM_004875
208910_s_at C1QBP complement component 1, q subcomponent binding protein 1 L04636
209893_s_at FUT4 fucosyltransferase 4 (alpha (1,3) fucosyltransferase, myeloid-specific) 1 M58596
210323_at TEKT2 tektin 2 (testicular) 1 AB033823
210567_s_at SKP2 S-phase kinase-associated protein 2 (p45) 1 BC001441
210787_s_at CAMKK2 calcium/calmodulin-dependent protein kinase kinase 2, beta 1 AF140507
212137_at LARP1 La ribonucleoprotein domain family, member 1 1 AV746402
213133_s_at GCSH ///
LOC730107
glycine cleavage system protein H (aminomethyl carrier) /// similar to
Glycine cleavage system H protein, mitochondrial precursor
1 AW237404
213416_at ITGA4 integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor) 1 BG532690
218238_at GTPBP4 GTP binding protein 4 1 NM_012341
218481_at EXOSC5 exosome component 5 1 NM_020158
218605_at TFB2 M transcription factor B2, mitochondrial 1 NM_022366
218826_at SLC35F2 solute carrier family 35, member F2 1 NM_017515
218877_s_at TRMT11 tRNA methyltransferase 11 homolog (S. cerevisiae) 1 NM_021820
221216_s_at SCMH1 sex comb on midleg homolog 1 (Drosophila) 1 NM_012236
221235_s_at LOC644617 Hypothetical LOC644617 /// Hypothetical LOC644617 1 NM_030825
221845_s_at CLPB ClpB caseinolytic peptidase B homolog (E. coli) 1 AI655698
201459_at RUVBL2 RuvB-like 2 (E. coli) 1.03 NM_006666
202349_at TOR1A torsin family 1, member A (torsin A) 1.03 NM_000113
202857_at TMEM4 transmembrane protein 4 1.03 NM_014255
204133_at RRP9 RRP9, small subunit (SSU) processome component, homolog (yeast) 1.03 NM_004704
204327_s_at ZNF202 zinc finger protein 202 1.03 N91520
204905_s_at EEF1E1 eukaryotic translation elongation factor 1 epsilon 1 1.03 NM_004280
205429_s_at MPP6 membrane protein, palmitoylated 6 (MAGUK p55 subfamily member 6) 1.03 NM_016447
205885_s_at ITGA4 integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor) 1.03 L12002
212295_s_at SLC7A1 solute carrier family 7 (cationic amino acid transporter, yþ system),
member 1
1.03 AA148507
212424_at PDCD11 programmed cell death 11 1.03 AW026194
218403_at TRIAP1 TP53 regulated inhibitor of apoptosis 1 1.03 NM_016399
218460_at HEATR2 HEAT repeat containing 2 1.03 NM_017802
200692_s_at HSPA9 heat shock 70 kDa protein 9 (mortalin) 1.05 NM_004134
201323_at EBNA1BP2 EBNA1 binding protein 2 1.05 NM_006824
206445_s_at PRMT1 protein arginine methyltransferase 1 1.05 NM_001536
207348_s_at LIG3 ligase III, DNA, ATP-dependent 1.05 NM_002311
207622_s_at ABCF2 ATP-binding cassette, sub-family F (GCN20), member 2 1.05 NM_005692
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208799_at PSMB5 proteasome (prosome, macropain) subunit, beta type, 5 1.05 BC004146
208972_s_at ATP5G1 ATP synthase, Hþ transporting, mitochondrial F0 complex, subunit
C1 (subunit 9)
1.05 AL080089
209098_s_at JAG1 jagged 1 (Alagille syndrome) 1.05 U61276
209262_s_at NR2F6 nuclear receptor subfamily 2, group F, member 6 1.05 BC002669
212422_at PDCD11 programmed cell death 11 1.05 AL547263
212693_at MDN1 MDN1, midasin homolog (yeast) 1.05 BE670928
212739_s_at NME4 non-metastatic cells 4, protein expressed in 1.05 AL523860
213838_at NOL7 nucleolar protein 7, 27 kDa 1.05 AA191426
217833_at SYNCRIP synaptotagmin binding, cytoplasmic RNA interacting protein 1.05 AL520908
218187_s_at C8orf33 chromosome 8 open reading frame 33 1.05 NM_023080
219731_at FLJ34077 weakly similar to zinc finger protein 195 1.05 NM_024343
219742_at PRR7 proline rich 7 (synaptic) 1.05 NM_030567
220416_at ATP8B4 ATPase, Class I, type 8B, member 4 1.05 NM_024837
50314_i_at C20orf27 chromosome 20 open reading frame 27 1.05 AI761506
201423_s_at CUL4A cullin 4A 1.08 AL037208
202212_at PES1 pescadillo homolog 1, containing BRCT domain (zebrafish) 1.08 NM_014303
202246_s_at CDK4 cyclin-dependent kinase 4 1.08 NM_000075
202264_s_at TOMM40 translocase of outer mitochondrial membrane 40 homolog (yeast) 1.08 NM_006114
203228_at PAFAH1B3 platelet-activating factor acetylhydrolase, isoform Ib, gamma subunit
29 kDa
1.08 NM_002573
203857_s_at PDIA5 protein disulfide isomerase family A, member 5 1.08 NM_006810
204169_at IMPDH1 IMP (inosine monophosphate) dehydrogenase 1 1.08 NM_000883
205241_at SCO2 SCO cytochrome oxidase deficient homolog 2 (yeast) 1.08 NM_005138
205761_s_at DUS4L dihydrouridine synthase 4-like (S. cerevisiae) 1.08 AW242981
205768_s_at SLC27A2 solute carrier family 27 (fatty acid transporter), member 2 1.08 NM_003645
207824_s_at MAZ MYC-associated zinc finger protein (purine-binding transcription factor) 1.08 NM_002383
210044_s_at LYL1 lymphoblastic leukemia derived sequence 1 1.08 BC002796
214173_x_at C19orf2 chromosome 19 open reading frame 2 1.08 AW514900
214507_s_at EXOSC2 exosome component 2 1.08 NM_014285
215073_s_at NR2F2 nuclear receptor subfamily 2, group F, member 2 1.08 AL554245
216952_s_at LMNB2 lamin B2 1.08 M94363
217832_at SYNCRIP synaptotagmin binding, cytoplasmic RNA interacting protein 1.08 BE672181
218145_at TRIB3 tribbles homolog 3 (Drosophila) 1.08 NM_021158
218529_at CD320 CD320 molecule 1.08 NM_016579
218767_at REXO4 REX4, RNA exonuclease 4 homolog (S. cerevisiae) 1.08 NM_020385
220892_s_at PSAT1 phosphoserine aminotransferase 1 1.08 NM_021154
202089_s_at SLC39A6 solute carrier family 39 (zinc transporter), member 6 1.1 NM_012319
202159_at FARSLA phenylalanine-tRNA synthetase-like, alpha subunit 1.1 NM_004461
202875_s_at PBX2 pre-B-cell leukemia transcription factor 2 1.1 BE397715
203093_s_at TIMM44 translocase of inner mitochondrial membrane 44 homolog (yeast) 1.1 NM_006351
204823_at NAV3 neuron navigator 3 1.1 NM_014903
205884_at ITGA4 integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor) 1.1 NM_000885
209921_at SLC7A11 solute carrier family 7, (cationic amino acid transporter, yþ system)
member 11
1.1 AB040875
210966_x_at LARP1 La ribonucleoprotein domain family, member 1 1.1 BC001460
211162_x_at SCD stearoyl-CoA desaturase (delta-9-desaturase) 1.1 AF116616
211367_s_at CASP1 caspase 1, apoptosis-related cysteine peptidase (interleukin 1, beta,
convertase)
1.1 U13699
211686_s_at RBM13 RNA binding motif protein 13 /// RNA binding motif protein 13 1.1 AF251062
214427_at NOL1 nucleolar protein 1, 120 kDa 1.1 NM_006170
214627_at EPX eosinophil peroxidase 1.1 X14346
215152_at MYB v-myb myeloblastosis viral oncogene homolog (avian) 1.1 AI357042
218618_s_at FNDC3B fibronectin type III domain containing 3B 1.1 NM_022763
219869_s_at SLC39A8 solute carrier family 39 (zinc transporter), member 8 1.1 NM_022154
200924_s_at SLC3A2 solute carrier family 3 (activators of dibasic and neutral amino acid
transport), member 2
1.13 NM_002394
201014_s_at PAICS phosphoribosylaminoimidazole carboxylase, phosphoribosylaminoimidazole
succinocarboxamide synthetase
1.13 NM_006452
202088_at SLC39A6 solute carrier family 39 (zinc transporter), member 6 1.13 AI635449
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202441_at SPFH1 SPFH domain family, member 1 1.13 AL568449
203612_at BYSL bystin-like 1.13 NM_004053
205090_s_at NAGPA N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase 1.13 NM_016256
205895_s_at NOLC1 nucleolar and coiled-body phosphoprotein 1 1.13 NM_004741
212528_at — CDNA clone IMAGE:3878236 1.13 AI348009
217754_at DDX56 DEAD (Asp-Glu-Ala-Asp) box polypeptide 56 1.13 NM_019082
218408_at TIMM10 translocase of inner mitochondrial membrane 10 homolog (yeast) 1.13 NM_012456
218969_at Magmas mitochondria-associated protein involved in granulocyte-macrophage
colony-stimulating factor signal transduction
1.13 NM_016069
203782_s_at POLRMT polymerase (RNA) mitochondrial (DNA directed) 1.15 NM_005035
203893_at TAF9 TAF9 RNA polymerase II, TATA box binding protein (TBP)-associated
factor, 32 kDa
1.15 NM_016283
203949_at MPO myeloperoxidase 1.15 NM_000250
205135_s_at NUFIP1 nuclear fragile X mental retardation protein interacting protein 1 1.15 AL049842
205748_s_at RNF126 ring finger protein 126 1.15 NM_017876
209121_x_at NR2F2 nuclear receptor subfamily 2, group F, member 2 1.15 M64497
210627_s_at GCS1 glucosidase I 1.15 BC002804
212411_at IMP4 IMP4, U3 small nucleolar ribonucleoprotein, homolog (yeast) 1.15 BE747342
213638_at PHACTR1 phosphatase and actin regulator 1 1.15 AW054711
218512_at WDR12 WD repeat domain 12 1.15 NM_018256
218593_at RBM28 RNA binding motif protein 28 1.15 NM_018077
219558_at ATP13A3 ATPase type 13A3 1.15 NM_024524
200691_s_at HSPA9 heat shock 70 kDa protein 9 (mortalin) 1.18 BC000478
201479_at DKC1 dyskeratosis congenita 1, dyskerin 1.18 NM_001363
202016_at MEST mesoderm specific transcript homolog (mouse) 1.18 NM_002402
202475_at TMEM147 transmembrane protein 147 1.18 NM_006326
202655_at ARMET arginine-rich, mutated in early stage tumors 1.18 NM_006010
203871_at SENP3 SUMO1/sentrin/SMT3 specific peptidase 3 1.18 NM_015670
204999_s_at ATF5 activating transcription factor 5 1.18 BC005174
211709_s_at CLEC11A C-type lectin domain family 11, member A 1.18 BC005810
211949_s_at NOLC1 nucleolar and coiled-body phosphoprotein 1 1.18 AI355279
213116_at NEK3 NIMA (never in mitosis gene a)-related kinase 3 1.18 AI191920
213132_s_at MCAT malonyl CoA:ACP acyltransferase (mitochondrial) 1.18 AL022237
217099_s_at GEMIN4 gem (nuclear organelle) associated protein 4 1.18 AF258545
64900_at FLJ22167 hypothetical protein FLJ22167 1.18 AA401703
203092_at TIMM44 translocase of inner mitochondrial membrane 44 homolog (yeast) 1.2 AF026030




defensin, alpha 1 /// defensin, alpha 3, neutrophil-specific /// similar to
Neutrophil defensin 1 precursor (HNP-1) (HP-1) (HP1)
(Defensin, alpha 1)
1.2 NM_004084
205769_at SLC27A2 solute carrier family 27 (fatty acid transporter), member 2 1.2 NM_003645
207396_s_at ALG3 asparagine-linked glycosylation 3 homolog (S. cerevisiae, alpha-1,3-
mannosyltransferase)
1.2 NM_005787
207624_s_at RPGR retinitis pigmentosa GTPase regulator 1.2 NM_000328
208676_s_at DLST /// PA2G4 dihydrolipoamide S-succinyltransferase (E2 component of 2-oxo-glutarate
complex) /// proliferation-associated 2G4, 38 kDa
1.2 U87954
208744_x_at HSPH1 heat shock 105 kDa/110 kDa protein 1 1.2 BG403660
209215_at TETRAN tetracycline transporter-like protein 1.2 L11669
210830_s_at PON2 paraoxonase 2 1.2 AF001602
211150_s_at DLAT dihydrolipoamide S-acetyltransferase (E2 component of pyruvate
dehydrogenase complex)
1.2 J03866
215983_s_at UBXD6 UBX domain containing 6 1.2 D83768
218774_at DCPS decapping enzyme, scavenger 1.2 NM_014026
200690_at HSPA9 heat shock 70 kDa protein 9 (mortalin) 1.23 AA927701
202148_s_at PYCR1 pyrroline-5-carboxylate reductase 1 1.23 NM_006907
203010_at STAT5A signal transducer and activator of transcription 5A 1.23 NM_003152
203712_at KIAA0020 KIAA0020 1.23 NM_014878
204998_s_at ATF5 activating transcription factor 5 1.23 NM_012068
206440_at LIN7A lin-7 homolog A (C. elegans) 1.23 NM_004664
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206752_s_at DFFB DNA fragmentation factor, 40 kDa, beta polypeptide (caspase-activated
DNase)
1.23 NM_004402
212791_at FLJ38984 hypothetical protein FLJ38984 1.23 AL042729
213170_at GPX7 glutathione peroxidase 7 1.23 AA406605
218027_at MRPL15 mitochondrial ribosomal protein L15 1.23 NM_014175
218069_at XTP3TPA XTP3-transactivated protein A 1.23 NM_024096
218112_at MRPS34 mitochondrial ribosomal protein S34 1.23 NM_023936
220615_s_at MLSTD1 male sterility domain containing 1 1.23 NM_018099
201478_s_at DKC1 dyskeratosis congenita 1, dyskerin 1.25 U59151
202453_s_at GTF2H1 general transcription factor IIH, polypeptide 1, 62 kDa 1.25 NM_005316
203230_at DVL1 ///
LOC642469
dishevelled, dsh homolog 1 (Drosophila) /// similar to dishevelled 1
isoform a
1.25 AF006011
203701_s_at TRMT1 TRM1 tRNA methyltransferase 1 homolog (S. cerevisiae) 1.25 NM_017722
209120_at NR2F2 nuclear receptor subfamily 2, group F, member 2 1.25 AL037401
212174_at AK2 adenylate kinase 2 1.25 W02312
213355_at ST3GAL6 ST3 beta-galactoside alpha-2,3-sialyltransferase 6 1.25 AI989567
219006_at C6orf66 chromosome 6 open reading frame 66 1.25 NM_014165
222206_s_at NCLN nicalin homolog (zebrafish) 1.25 AA781143
204394_at SLC43A1 solute carrier family 43, member 1 1.28 NM_003627
205565_s_at FXN frataxin 1.28 NM_000144
210463_x_at TRMT1 TRM1 tRNA methyltransferase 1 homolog (S. cerevisiae) 1.28 BC002492
211728_s_at HYAL3 hyaluronoglucosaminidase 3 /// hyaluronoglucosaminidase 3 1.28 BC005896
212173_at AK2 adenylate kinase 2 1.28 AU154985
212193_s_at LARP1 La ribonucleoprotein domain family, member 1 1.28 BE881529
219031_s_at NIP7 nuclear import 7 homolog (S. cerevisiae) 1.28 NM_016101
221987_s_at TSR1 TSR1, 20S rRNA accumulation, homolog (S. cerevisiae) 1.28 AI803633
201577_at NME1 non-metastatic cells 1, protein (NM23A) expressed in 1.3 NM_000269
202799_at CLPP ClpP caseinolytic peptidase, ATP-dependent, proteolytic subunit homolog
(E. coli)
1.3 NM_006012
203685_at BCL2 B-cell CLL/lymphoma 2 1.3 NM_000633
205129_at NPM3 nucleophosmin/nucleoplasmin, 3 1.3 NM_006993
205977_s_at EPHA1 EPH receptor A1 1.3 NM_005232
206039_at RAB33A RAB33A, member RAS oncogene family 1.3 NM_004794
211774_s_at MMACHC methylmalonic aciduria (cobalamin deficiency) cblC type, with
homocystinuria
1.3 BC006122
211936_at HSPA5 heat shock 70 kDa protein 5 (glucose-regulated protein, 78 kDa) 1.3 AF216292
214523_at CEBPE CCAAT/enhancer binding protein (C/EBP), epsilon 1.3 NM_001805
218001_at MRPS2 mitochondrial ribosomal protein S2 1.3 NM_016034
218188_s_at TIMM13 translocase of inner mitochondrial membrane 13 homolog (yeast) 1.3 NM_012458
218586_at C20orf20 chromosome 20 open reading frame 20 1.3 NM_018270
218708_at NXT1 NTF2-like export factor 1 1.3 NM_013248
219110_at NOLA1 nucleolar protein family A, member 1 (H/ACA small nucleolar RNPs) 1.3 NM_018983
219158_s_at NARG1 NMDA receptor regulated 1 1.3 NM_025085
219218_at BAHCC1 BAH domain and coiled-coil containing 1 1.3 NM_024696
219420_s_at C1orf163 chromosome 1 open reading frame 163 1.3 NM_023077
220587_s_at GBL G protein beta subunit-like 1.3 NM_022372
201797_s_at VARS valyl-tRNA synthetase 1.33 NM_006295
203721_s_at UTP18 UTP18, small subunit (SSU) processome component, homolog (yeast) 1.33 NM_016001
203931_s_at MRPL12 mitochondrial ribosomal protein L12 1.33 NM_002949
205996_s_at AK2 adenylate kinase 2 1.33 NM_013411
207398_at HOXD13 homeobox D13 1.33 NM_000523
212627_s_at EXOSC7 exosome component 7 1.33 AL581473
214794_at DLST dihydrolipoamide S-succinyltransferase (E2 component of 2-oxo-glutarate
complex)
1.33 BF669264
215947_s_at FLJ14668 hypothetical protein FLJ14668 1.33 AF090094
218278_at WDR74 WD repeat domain 74 1.33 NM_018093
218681_s_at SDF2L1 stromal cell-derived factor 2-like 1 1.33 NM_022044
221758_at ARMC6 armadillo repeat containing 6 1.33 BC003700
202740_at ACY1 aminoacylase 1 1.35 NM_000666
204381_at LRP3 low density lipoprotein receptor-related protein 3 1.35 NM_002333
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209233_at EMG1 EMG1 nucleolar protein homolog (S. cerevisiae) 1.35 U72514
212218_s_at FASN fatty acid synthase 1.35 AI954041
218322_s_at ACSL5 acyl-CoA synthetase long-chain family member 5 1.35 NM_016234
220417_s_at THAP4 ///
LOC728944
THAP domain containing 4 /// similar to THAP domain-containing
protein 4
1.35 NM_015963
221692_s_at MRPL34 mitochondrial ribosomal protein L34 /// mitochondrial ribosomal
protein L34
1.35 AB049652
201587_s_at IRAK1 interleukin-1 receptor-associated kinase 1 1.38 NM_001569
201819_at SCARB1 scavenger receptor class B, member 1 1.38 NM_005505
204175_at ZNF593 zinc finger protein 593 1.38 NM_015871
204852_s_at PTPN7 protein tyrosine phosphatase, non-receptor type 7 1.38 NM_002832
209409_at GRB10 growth factor receptor-bound protein 10 1.38 D86962
209516_at SMYD5 SMYD family member 5 1.38 U50383
212432_at GRPEL1 GrpE-like 1, mitochondrial (E. coli) 1.38 AL542571
218695_at EXOSC4 exosome component 4 1.38 NM_019037
219559_at C20orf59 chromosome 20 open reading frame 59 1.38 NM_022082
220234_at CA8 carbonic anhydrase VIII 1.38 NM_004056
203622_s_at PNO1 partner of NOB1 homolog (S. cerevisiae) 1.4 NM_020143
205527_s_at GEMIN4 gem (nuclear organelle) associated protein 4 1.4 NM_015487
209196_at WDR46 WD repeat domain 46 1.4 BC000388
214022_s_at IFITM1 interferon induced transmembrane protein 1 (9-27) 1.4 AA749101
218710_at TTC27 tetratricopeptide repeat domain 27 1.4 NM_017735
200598_s_at HSP90B1 heat shock protein 90 kDa beta (Grp94), member 1 1.43 AI582238
201601_x_at IFITM1 interferon induced transmembrane protein 1 (9-27) 1.43 NM_003641




annexin A8 /// annexin A8-like 1 /// similar to Annexin A8
(Annexin VIII) (Vascular anticoagulant-beta) (VAC-beta)
1.43 NM_001630
204019_s_at SH3YL1 SH3 domain containing, Ysc84-like 1 (S. cerevisiae) 1.43 NM_015677
205883_at ZBTB16 zinc finger and BTB domain containing 16 1.43 NM_006006
209567_at RRS1 RRS1 ribosome biogenesis regulator homolog (S. cerevisiae) 1.43 BC001811
213302_at PFAS phosphoribosylformylglycinamidine synthase (FGAR amidotransferase) 1.43 AL044326
221766_s_at FAM46A family with sequence similarity 46, member A 1.43 AW246673
65588_at LOC388796 hypothetical LOC388796 1.43 AA827892
203867_s_at NLE1 notchless homolog 1 (Drosophila) 1.45 NM_018096
204548_at STAR steroidogenic acute regulator 1.45 NM_000349
205891_at ADORA2B adenosine A2b receptor 1.45 NM_000676
210999_s_at GRB10 growth factor receptor-bound protein 10 1.45 U66065
212512_s_at CARM1 coactivator-associated arginine methyltransferase 1 1.45 AA551784
213861_s_at FAM119B family with sequence similarity 119, member B 1.45 N67741
221772_s_at PPP2R2D protein phosphatase 2, regulatory subunit B, delta isoform 1.45 AI138993
201925_s_at CD55 CD55 molecule, decay accelerating factor for complement
(Cromer blood group)
1.48 NM_000574
208152_s_at DDX21 DEAD (Asp-Glu-Ala-Asp) box polypeptide 21 1.48 NM_004728
212680_x_at PPP1R14B protein phosphatase 1, regulatory (inhibitor) subunit 14B 1.48 BE305165
201563_at SORD sorbitol dehydrogenase 1.5 L29008
203973_s_at CEBPD CCAAT/enhancer binding protein (C/EBP), delta 1.5 NM_005195
205774_at F12 coagulation factor XII (Hageman factor) 1.5 NM_000505
210783_x_at CLEC11A C-type lectin domain family 11, member A 1.5 D86586
212110_at SLC39A14 solute carrier family 39 (zinc transporter), member 14 1.5 D31887
212456_at KIAA0664 KIAA0664 1.5 AB014564
213097_s_at ZRF1 zuotin related factor 1 1.5 AI338837
219581_at TSEN2 tRNA splicing endonuclease 2 homolog (S. cerevisiae) 1.5 NM_025265
201516_at SRM spermidine synthase 1.53 NM_003132
218670_at PUS1 pseudouridylate synthase 1 1.53 NM_025215
220446_s_at CHST4 carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 4 1.53 NM_005769
203997_at PTPN3 protein tyrosine phosphatase, non-receptor type 3 1.55 NM_002829
204521_at C12orf24 chromosome 12 open reading frame 24 1.55 NM_013300
204695_at CDC25A cell division cycle 25 homolog A (S. cerevisiae) 1.55 AI343459
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206397_x_at GDF1 /// LASS1 growth differentiation factor 1 /// LAG1 homolog, ceramide
synthase 1 (S. cerevisiae)
1.55 NM_001492
208712_at CCND1 cyclin D1 1.55 M73554
213113_s_at SLC43A3 solute carrier family 43, member 3 1.55 AI630178
213823_at HOXA11 homeobox A11 1.55 H94842
216602_s_at FARSLA phenylalanine-tRNA synthetase-like, alpha subunit 1.55 AD000092
203150_at RABEPK Rab9 effector protein with kelch motifs 1.58 NM_005833
204027_s_at METTL1 methyltransferase like 1 1.58 NM_005371
205349_at GNA15 guanine nucleotide binding protein (G protein), alpha 15 (Gq class) 1.58 NM_002068
205945_at IL6R interleukin 6 receptor /// interleukin 6 receptor 1.58 NM_000565
206613_s_at TAF1A TATA box binding protein (TBP)-associated factor, RNA polymerase
I, A, 48 kDa
1.58 NM_005681
218199_s_at NOL6 nucleolar protein family 6 (RNA-associated) 1.58 NM_022917
218886_at PAK1IP1 ///
C20orf7
PAK1 interacting protein 1 /// chromosome 20 open reading frame 7 1.58 NM_017906
202431_s_at MYC v-myc myelocytomatosis viral oncogene homolog (avian) 1.6 NM_002467
202444_s_at SPFH1 SPFH domain family, member 1 1.6 NM_006459
203737_s_at PPRC1 peroxisome proliferator-activated receptor gamma, coactivator-related 1 1.6 NM_015062
218358_at CCNK Cyclin K 1.6 NM_024324
219837_s_at CYTL1 cytokine-like 1 1.6 NM_018659
221712_s_at WDR74 WD repeat domain 74 /// WD repeat domain 74 1.6 BC006351
200952_s_at CCND2 cyclin D2 1.63 AI635187
216212_s_at DKC1 dyskeratosis congenita 1, dyskerin 1.63 AJ010395
219324_at TRIOBP ///
NOL12
TRIO and F-actin binding protein /// nucleolar protein 12 1.63 NM_024313
220051_at PRSS21 protease, serine, 21 (testisin) 1.63 NM_006799




carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and
dihydroorotase /// Rho guanine nucleotide exchange factor (GEF) 5 ///
FLJ40722-like
1.65 NM_004341
209930_s_at NFE2 nuclear factor (erythroid-derived 2), 45 kDa 1.65 L13974
210147_at ART3 ADP-ribosyltransferase 3 1.65 U47054
216449_x_at HSP90B1 heat shock protein 90 kDa beta (Grp94), member 1 1.65 AK025862
218156_s_at TSR1 TSR1, 20S rRNA accumulation, homolog (S. cerevisiae) 1.65 NM_018128
200659_s_at PHB prohibitin 1.68 NM_002634
200895_s_at FKBP4 FK506 binding protein 4, 59 kDa 1.68 NM_002014






fatty acid binding protein 5 (psoriasis-associated) /// similar to Fatty
acid-binding protein, epidermal (E-FABP) (Psoriasis-associated fatty
acid-binding protein homolog) (PA-FABP) /// similar to Fatty acid-
binding protein, epidermal (E-FABP) (Psoriasis-
1.68 NM_001444
206111_at RNASE2 ribonuclease, RNase A family, 2 (liver, eosinophil-derived neurotoxin) 1.68 NM_002934
209892_at FUT4 fucosyltransferase 4 (alpha (1,3) fucosyltransferase, myeloid-specific) 1.68 AF305083
217489_s_at IL6R interleukin 6 receptor 1.68 S72848
200953_s_at CCND2 cyclin D2 1.7 NM_001759
204514_at DPH2 DPH2 homolog (S. cerevisiae) 1.7 NM_001384
206653_at POLR3 G polymerase (RNA) III (DNA directed) polypeptide G (32kD) 1.7 BF062139
214369_s_at RASGRP2 RAS guanyl releasing protein 2 (calcium and DAG-regulated) 1.7 AI688812
218893_at ISOC2 isochorismatase domain containing 2 1.7 NM_024710
200894_s_at FKBP4 FK506 binding protein 4, 59 kDa 1.73 AA894574
203397_s_at GALNT3 UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-
acetylgalactosaminyltransferase 3 (GalNAc-T3)
1.73 BF063271
211715_s_at BDH1 3-hydroxybutyrate dehydrogenase, type 1 /// 3-hydroxybutyrate
dehydrogenase, type 1
1.73 BC005844
219361_s_at ISG20L1 interferon stimulated exonuclease gene 20 kDa-like 1 1.73 NM_022767
201562_s_at SORD ///
LOC653381
sorbitol dehydrogenase /// similar to Sorbitol dehydrogenase (L-iditol
2-dehydrogenase)
1.75 NM_003104
203948_s_at MPO myeloperoxidase 1.75 J02694
209710_at GATA2 GATA binding protein 2 1.75 AL563460
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219295_s_at PCOLCE2 procollagen C-endopeptidase enhancer 2 1.75 NM_013363
221586_s_at E2F5 E2F transcription factor 5, p130-binding 1.75 U15642




A kinase (PRKA) anchor protein 2 /// PALM2-AKAP2 protein 1.78 BE879367
205896_at SLC22A4 solute carrier family 22 (organic cation transporter), member 4 1.78 NM_003059
213524_s_at G0S2 G0/G1switch 2 1.78 NM_015714
218590_at PEO1 progressive external ophthalmoplegia 1 1.78 NM_021830
201841_s_at HSPB1 ///
MEIS3
heat shock 27 kDa protein 1 /// Meis1, myeloid ecotropic viral
integration site 1 homolog 3 (mouse)
1.8 NM_001540
204087_s_at SLC5A6 solute carrier family 5 (sodium-dependent vitamin transporter),
member 6
1.8 NM_021095
205131_x_at CLEC11A C-type lectin domain family 11, member A 1.8 NM_002975
205471_s_at DACH1 dachshund homolog 1 (Drosophila) 1.8 AW772082
210692_s_at SLC43A3 solute carrier family 43, member 3 1.8 BC003163
213142_x_at LOC54103 hypothetical protein LOC54103 1.8 AV700415
216950_s_at FCGR1A Fc fragment of IgG, high affinity Ia, receptor (CD64) 1.8 X14355
205476_at CCL20 chemokine (C-C motif) ligand 20 1.83 NM_004591
209731_at NTHL1 nth endonuclease III-like 1 (E. coli) 1.83 U79718
60474_at C20orf42 chromosome 20 open reading frame 42 1.83 AA469071
201796_s_at VARS valyl-tRNA synthetase 1.85 BE790854
209777_s_at SLC19A1 solute carrier family 19 (folate transporter), member 1 1.85 AF004354
201508_at IGFBP4 insulin-like growth factor binding protein 4 1.88 NM_001552
201695_s_at NP nucleoside phosphorylase 1.88 NM_000270
204301_at KBTBD11 kelch repeat and BTB (POZ) domain containing 11 1.88 NM_014867
221648_s_at — — 1.88 AK025651
203148_s_at TRIM14 tripartite motif-containing 14 1.9 NM_014788
211576_s_at SLC19A1 solute carrier family 19 (folate transporter), member 1 1.9 BC003068
214575_s_at AZU1 azurocidin 1 (cationic antimicrobial protein 37) 1.9 NM_001700
214011_s_at HSPC111 hypothetical protein HSPC111 1.93 BE314601
214511_x_at FCGR1B Fc fragment of IgG, high affinity Ib, receptor (CD64) 1.93 L03419
216913_s_at RRP12 ribosomal RNA processing 12 homolog (S. cerevisiae) 1.93 AK021460
202760_s_at AKAP2 ///
PALM2-AKAP2
A kinase (PRKA) anchor protein 2 /// PALM2-AKAP2 protein 1.95 NM_007203
206655_s_at GP1BB /// SEPT5 glycoprotein Ib (platelet), beta polypeptide /// septin 5 1.95 NM_000407
216667_at RNASE2 ///
LOC643332
ribonuclease, RNase A family, 2 (liver, eosinophil-derived neurotoxin) ///
similar to Nonsecretory ribonuclease precursor (Ribonuclease US)
(Eosinophil-derived neurotoxin) (RNase UpI-2) (Ribonuclease 2)
(RNase 2)
1.95 X55989
204647_at HOMER3 homer homolog 3 (Drosophila) 1.98 NM_004838
210008_s_at MRPS12 mitochondrial ribosomal protein S12 1.98 AA513737
220688_s_at MRT4 mRNA turnover 4 homolog (S. cerevisiae) 1.98 NM_016183
204717_s_at SLC29A2 solute carrier family 29 (nucleoside transporters), member 2 2 AF034102
205419_at EBI2 Epstein-Barr virus induced gene 2 (lymphocyte-specific G protein-
coupled receptor)
2 NM_004951
201195_s_at SLC7A5 solute carrier family 7 (cationic amino acid transporter, yþ system),
member 5
2.03 AB018009
208206_s_at RASGRP2 RAS guanyl releasing protein 2 (calcium and DAG-regulated) 2.03 NM_005825
209100_at IFRD2 interferon-related developmental regulator 2 2.03 BC001327
203023_at HSPC111 hypothetical protein HSPC111 2.05 NM_016391
204798_at MYB v-myb myeloblastosis viral oncogene homolog (avian) 2.05 NM_005375
210140_at CST7 cystatin F (leukocystatin) 2.05 AF031824
203119_at CCDC86 coiled-coil domain containing 86 2.08 NM_024098
213395_at MLC1 megalencephalic leukoencephalopathy with subcortical cysts 1 2.13 AL022327
206851_at RNASE3 ribonuclease, RNase A family, 3 (eosinophil cationic protein) 2.18 NM_002935




T cell receptor gamma constant 2 /// T cell receptor gamma variable 9 ///
TCR gamma alternate reading frame protein
2.23 M13231
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216920_s_at TRGC2 /// TRGV9
/// TARP
T cell receptor gamma constant 2 /// T cell receptor gamma variable 9 ///
TCR gamma alternate reading frame protein
2.23 M27331
218305_at IPO4 importin 4 2.23 NM_024658
222150_s_at LOC54103 hypothetical protein LOC54103 2.23 AK026747
214452_at BCAT1 branched chain aminotransferase 1, cytosolic 2.25 NM_005504
215489_x_at HOMER3 homer homolog 3 (Drosophila) 2.25 AI871287
221270_s_at QTRT1 queuine tRNA-ribosyltransferase 1 (tRNA-guanine transglycosylase) ///
queuine tRNA-ribosyltransferase 1 (tRNA-guanine transglycosylase)
2.3 NM_031209
200951_s_at CCND2 cyclin D2 2.33 AW026491




T cell receptor gamma constant 2 /// T cell receptor gamma constant 2 /// T
cell receptor gamma variable 9 /// T cell receptor gamma variable 9 /// TCR






T cell receptor gamma constant 2 /// T cell receptor gamma variable 9 ///
TCR gamma alternate reading frame protein
2.38 M30894
219911_s_at SLCO4A1 solute carrier organic anion transporter family, member 4A1 2.38 NM_016354
206103_at RAC3 ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding
protein Rac3)
2.4 NM_005052
207397_s_at HOXD13 homeobox D13 2.4 NM_000523
205130_at RAGE renal tumor antigen 2.43 NM_014226
209906_at C3AR1 complement component 3a receptor 1 2.45 U62027
211382_s_at TACC2 transforming, acidic coiled-coil containing protein 2 2.45 AF220152
214390_s_at BCAT1 branched chain aminotransferase 1, cytosolic 2.48 AI652662
220112_at ANKRD55 ankyrin repeat domain 55 2.48 NM_024669
203548_s_at LPL lipoprotein lipase 2.5 BF672975
210036_s_at KCNH2 potassium voltage-gated channel, subfamily H (eag-related), member 2 2.5 AB044806
221197_s_at CHAT choline acetyltransferase 2.53 NM_020985
214240_at GAL galanin 2.55 AL556409
210755_at HGF hepatocyte growth factor (hepapoietin A; scatter factor) 2.6 U46010
209129_at TRIP6 thyroid hormone receptor interactor 6 2.65 AF000974
214788_x_at DDN dendrin 2.73 AA731713
202382_s_at GNPDA1 glucosamine-6-phosphate deaminase 1 2.75 NM_005471
220798_x_at PRG2 plasticity-related gene 2 2.83 NM_024888
204163_at EMILIN1 elastin microfibril interfacer 1 2.85 NM_007046
219926_at POPDC3 popeye domain containing 3 2.9 NM_022361
218796_at C20orf42 chromosome 20 open reading frame 42 2.93 NM_017671
205472_s_at DACH1 dachshund homolog 1 (Drosophila) 2.95 NM_004392
211273_s_at TBX1 T-box 1 2.95 AF012130
209775_x_at SLC19A1 solute carrier family 19 (folate transporter), member 1 3.08 AI917627
209776_s_at SLC19A1 solute carrier family 19 (folate transporter), member 1 3.2 U15939
211966_at COL4A2 collagen, type IV, alpha 2 3.33 AA909035
207199_at TERT telomerase reverse transcriptase 3.38 NM_003219
201667_at GJA1 gap junction protein, alpha 1, 43 kDa (connexin 43) 3.45 NM_000165
206277_at P2RY2 purinergic receptor P2Y, G-protein coupled, 2 3.5 NM_002564
211964_at COL4A2 collagen, type IV, alpha 2 3.55 X05610
219799_s_at DHRS9 dehydrogenase/reductase (SDR family) member 9 3.58 NM_005771
204420_at FOSL1 FOS-like antigen 1 3.6 BG251266
217143_s_at TRA@ ///
TRD@




T cell receptor alpha locus /// T cell receptor delta locus /// B-cell CLL/
lymphoma 11B (zinc finger protein)
3.65 X72501
207341_at PRTN3 proteinase 3 (serine proteinase, neutrophil, Wegener granulomatosis
autoantigen)
3.7 NM_002777
222222_s_at HOMER3 homer homolog 3 (Drosophila) 3.7 AC002985
213589_s_at B3GNTL1 UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase-like 1 3.85 AW468201
207067_s_at HDC histidine decarboxylase 4 NM_002112
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210254_at MS4A3 membrane-spanning 4-domains, subfamily A, member 3 (hematopoietic
cell-specific)
4.03 L35848
205653_at CTSG cathepsin G 4.35 NM_001911
213830_at TRA@ T cell receptor alpha locus 4.45 AW007751
205262_at KCNH2 potassium voltage-gated channel, subfamily H (eag-related), member 2 4.68 NM_000238
219491_at LRFN4 leucine rich repeat and fibronectin type III domain containing 4 5.08 NM_024036
209960_at HGF hepatocyte growth factor (hepapoietin A; scatter factor) 6.6 X16323
SLR 5 signal log ratio.
Supplementary Table E3A. GO Categories increased in WEB-2170-
treated vs untreated NB4 cells




negative regulation of cell proliferation 3.08E-04
apoptosis 3.27E-04
programmed cell death 3.41E-04
regulation of apoptosis 0
regulation of programmed cell death 0
regulation of cell cycle 0.01
negative regulation of progression through cell cycle 0.01
positive regulation of biological process 0.01
positive regulation of apoptosis 0.01
positive regulation of programmed cell death 0.01
regulation of progression through cell cycle 0.01
induction of programmed cell death 0.02
induction of apoptosis 0.02
response to stress 0.02
negative regulation of cell-matrix adhesion 0.03
apoptotic program 0.04
cellular catabolism 0.04
regulation of signal transduction 0.04
positive regulation of caspase activity 0.05
caspase activation 0.05
regulation of caspase activity 0.05
Supplementary Table E3B. GO Categories decreased in WEB-2170-
treated vs untreated NB4 cells
GO Name pValue
ribosome biogenesis and assembly 2.00E-09
RNA metabolism 9.12E-07
rRNA metabolism 2.85E-06








negative regulation of apoptosis 0.01
negative regulation of programmed cell death 0.01
cellular metabolism 0.01
di-, tri-valent inorganic cation homeostasis 0.01
protein import 0.01
amino acid metabolism 0.01
organelle organization and biogenesis 0.02
transcription from RNA polymerase II promoter 0.02
positive regulation of cell proliferation 0.03
regulation of cell cycle 0.03
cell cycle 0.03
regulation of apoptosis 0.03
regulation of programmed cell death 0.03
positive regulation of biological process 0.05
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